{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "# from rich import print"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "210"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "expDirList = [\n",
    "    os.path.join(\"data\", dirName)\n",
    "    for dirName in os.listdir(\"data\")\n",
    "    if os.path.isdir(os.path.join(\"data\", dirName))\n",
    "]\n",
    "len(expDirList)\n",
    "# expDirList"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'epidermoid carcinoma': 7, 'invasive breast cancer': 56, 'normal': 388, 'breast cancer': 903, 'pancreatic cancer': 222, 'ovarian carcinoma': 80, 'lung cancer': 91, 'ovarian cancer': 111, 'healthy': 53, 'clear cell renal carcinoma': 60, 'papillary renal cell carcinoma': 11, 'transitional cell carcinoma of kidney': 8, 'chromophobe renal cell carcinoma': 6, 'Kidney Oncocytoma': 12, 'colorectal adenocarcinoma': 59, 'breast carcinoma': 212, 'pancreatic carcinoma': 18, 'lung carcinoma': 27, 'squamous cell carcinoma': 21, 'prostate carcinoma': 195, 'non-small cell lung cancer': 158, 'breast adenocarcinoma': 111, 'hepatitis B virus induced hepatocellular carcinoma': 8, 'hepatitis C virus induced hepatocellular carcinoma': 12, 'non-small cell lung carcinoma': 310, 'gastric carcinoma': 130, 'pulmonary mucoepidermoid carcinoma': 12, 'pancreatic ductal adenocarcinoma': 12, 'control': 3, 'glioblastoma': 37, 'endometrial neoplasm': 81, 'adenocarcinoma': 101, 'benign': 10, 'gastric cancer': 32, 'gastric non-cardia carcinoma': 142, 'gastric cardia carcinoma': 126, 'brain glioblastoma': 6, 'fibrosarcoma': 24, 'ovarian adenocarcinoma': 40, 'invasive ductal carcinoma': 56, 'non small cell lung cancer': 46, 'chronic myelogenous leukemia (CML)': 1, 'benign prostate tumor': 6, 'primary prostate cancer': 7, 'metastatic prostate cancer': 18, 'breast ductal adenocarcinoma': 34, 'ductal carcinoma in situ': 3, 'lung metastasis': 6, 'cancer associated fibroblast': 3, 'aggressive androgen negative prostate cancer': 6, 'hepatocellular carcinoma': 57, 'colorectal cancer': 177, 'inflammatory bowel disease': 15, 'colon adenoma': 15, 'none': 8, 'lung adenocarcinoma': 57, 'PanIN lesion': 26, 'prostate cancer': 33, 'normal airway epithelia': 96, 'skin cancer': 8, 'non-inflammatory breast cancer': 40, 'inflammatory breast cancer': 40, 'osteosarcoma': 12, 'colon cancer': 6, 'renal adenocarcinoma': 18, 'metastatic malignant melanoma': 17, 'adenocarcinoma of lung': 84, 'AIDs related Burkitts lymphoma': 17, 'pancreatic adenocarcinoma': 18, \"lymphoblastic Burkitt's lymphoma\": 17, 'carcinoma, renal cell': 17, 'acute lymphoblastic (T-ALL) leukemia': 18, 'adenocarcinoma of colon': 90, 'malignant melanoma': 33, 'gastric adenocarcinoma': 17, 'colon carcinoma': 60, 'cervical adenocarcinoma': 17, 'promyelocytic leukemia': 18, 'large cell undifferentiated lung': 18, 'chronic myelogenous (blast crisis) leukemia': 17, 'malignant amelanocytic melanoma': 17, 'melanoma': 50, 'adenocarcinoma, breast grown from mouse mammary fat pad': 16, 'adenocarcinoma HER2/ERBB2 transfectant of MDA-MB-435 melanoma': 17, 'acute lymphoblastic leukemia': 18, 'squamous cell lung carcinoma': 15, 'large cell lung carcinoma': 18, 'adenocarcinoma of prostate': 17, 'adenocarcinoma prostate PC-3 subline isolated from liver metastasis in mice': 18, 'poorly differentiated hypernephroma': 18, 'anaplastic astrocytoma': 7, 'renal carcinoma': 17, 'poorly differentiated B cell origin leukemia': 18, 'papillary thyroid carcinoma': 6, 'malignant peripheral nerve sheath tumor': 9, 'bladder cancer': 6, 'chronic myelogenous leukemia': 34, 'cervical cancer': 6, 'small cell lung carcinoma': 79, 'pancreatic ductal carcinoma': 6, 'hyperplastic enlarged lobular unit': 8, 'normal terminal duct lobular unit': 8, 'carcinoma': 12, 'colon adenocarcinoma': 48, 'small cell lung cancer': 12, 'chronic obstructive pulmonary disease': 21, 'non-small cell lung cancer and chronic obstructive pulmonary disease': 13, 'head and neck cancer and chronic obstructive pulmonary disease': 7, 'head and neck cancer': 3, 'leukemia': 6, 'diffuse gastric adenocarcinoma': 6, 'gastric intestinal type adenocarcinoma': 6, 'glioma': 3, 'not applicable': 6, 'non-small cell lung adenocarcinoma': 30, 'actinic keratosis': 13, 'sebaceous of Jadassohn nevus': 7, 'oral squamous cell carcinoma': 49, 'high grade ovarian serous adenocarcinoma': 24, 'ductal carcinoma': 18, 'endometrial carcinoma': 12, 'high grade ovarian serous carcinoma': 70, 'ovarian serous adenocarcinoma': 6, 'laryngeal squamous cell carcinoma': 16}\n",
      "185\n"
     ]
    }
   ],
   "source": [
    "cancerCount = {}\n",
    "filteredOut = []\n",
    "cancerSpecificSignificantGenes = {}\n",
    "cancerTypeAnnotation = {}\n",
    "# IDcount = {}\n",
    "for dirPath in expDirList:\n",
    "    fileList = [\n",
    "        os.path.join(dirPath, fileName) for fileName in sorted(os.listdir(dirPath))\n",
    "    ]\n",
    "    designFilePath = [filePath for filePath in fileList if \"experiment\" in filePath]\n",
    "    design = pd.read_table(designFilePath[0])\n",
    "    if design.filter(regex=\"[^m]\\[disease\\]\").shape[1] == 0:\n",
    "        filteredOut.append(dirPath)\n",
    "        # print(dirPath, end=\"\")\n",
    "        # print(design)\n",
    "        continue\n",
    "    for cancerType in design.filter(regex=\"[^m]\\[disease\\]\").iloc[:, 0]:\n",
    "        cancerCount[cancerType] = cancerCount.get(cancerType, 0) + 1\n",
    "    cancerTypeAnnotation[os.path.basename(dirPath)] = design.filter(\n",
    "        regex=r\"Sample Characteristic\\[disease\\]\"\n",
    "    )\n",
    "    # for cancerType in design.filter(regex=\"[^m]\\[disease\\]\").columns:\n",
    "    #     # IDcount[dirPath] = IDcount.get(dirPath, 0) + 1\n",
    "    #     cancerCount[cancerType] = cancerCount.get(cancerType, 0) + 1\n",
    "\n",
    "print(cancerCount)\n",
    "# The cancer type annotation is redundant in some exp data\n",
    "# print(IDcount)\n",
    "\n",
    "for each in filteredOut:\n",
    "    expDirList.remove(each)\n",
    "print(len(expDirList))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "# print([anno.shape for anno in cancerTypeAnnotation.values()])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "columnNamesCount = {}\n",
    "\n",
    "for dirPath in expDirList:\n",
    "    analytics = pd.read_table(\n",
    "        os.path.join(\n",
    "            dirPath,\n",
    "            [fileName for fileName in os.listdir(dirPath) if \"analytic\" in fileName][0],\n",
    "        )\n",
    "    )\n",
    "    for colName in analytics.columns:\n",
    "        columnNamesCount[colName] = columnNamesCount.get(colName, 0) + 1\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'Gene ID': 185,\n",
       " 'Gene Name': 185,\n",
       " 'Design Element': 144,\n",
       " \"'gefitinib resistant' vs 'gefitinib sensitive'.p-value\": 1,\n",
       " \"'gefitinib resistant' vs 'gefitinib sensitive'.t-statistic\": 1,\n",
       " \"'gefitinib resistant' vs 'gefitinib sensitive'.log2foldchange\": 1,\n",
       " \"'stromal cell; invasive breast cancer' vs 'epithelial cell; invasive breast cancer'.p-value\": 1,\n",
       " \"'stromal cell; invasive breast cancer' vs 'epithelial cell; invasive breast cancer'.t-statistic\": 1,\n",
       " \"'stromal cell; invasive breast cancer' vs 'epithelial cell; invasive breast cancer'.log2foldchange\": 1,\n",
       " \"'stromal cell; normal' vs 'epithelial cell; normal'.p-value\": 1,\n",
       " \"'stromal cell; normal' vs 'epithelial cell; normal'.t-statistic\": 1,\n",
       " \"'stromal cell; normal' vs 'epithelial cell; normal'.log2foldchange\": 1,\n",
       " \"'MCF-7 clone 2A' vs 'MCF-7'.p-value\": 1,\n",
       " \"'MCF-7 clone 2A' vs 'MCF-7'.t-statistic\": 1,\n",
       " \"'MCF-7 clone 2A' vs 'MCF-7'.log2foldchange\": 1,\n",
       " \"'MCF-7 clone 5C' vs 'MCF-7'.p-value\": 1,\n",
       " \"'MCF-7 clone 5C' vs 'MCF-7'.t-statistic\": 1,\n",
       " \"'MCF-7 clone 5C' vs 'MCF-7'.log2foldchange\": 1,\n",
       " \"'10 nanomolar; estradiol' vs 'vehicle' at '24 hour'.p-value\": 1,\n",
       " \"'10 nanomolar; estradiol' vs 'vehicle' at '24 hour'.t-statistic\": 1,\n",
       " \"'10 nanomolar; estradiol' vs 'vehicle' at '24 hour'.log2foldchange\": 1,\n",
       " \"'10 nanomolar; estradiol' vs 'vehicle' at '12 hour'.p-value\": 1,\n",
       " \"'10 nanomolar; estradiol' vs 'vehicle' at '12 hour'.t-statistic\": 1,\n",
       " \"'10 nanomolar; estradiol' vs 'vehicle' at '12 hour'.log2foldchange\": 1,\n",
       " \"'10 nanomolar; estradiol' vs 'vehicle' at '48 hour'.p-value\": 1,\n",
       " \"'10 nanomolar; estradiol' vs 'vehicle' at '48 hour'.t-statistic\": 1,\n",
       " \"'10 nanomolar; estradiol' vs 'vehicle' at '48 hour'.log2foldchange\": 1,\n",
       " \"'17beta-estradiol; 100 nanomolar; wild type' vs 'ethanol; wild type'.p-value\": 1,\n",
       " \"'17beta-estradiol; 100 nanomolar; wild type' vs 'ethanol; wild type'.t-statistic\": 1,\n",
       " \"'17beta-estradiol; 100 nanomolar; wild type' vs 'ethanol; wild type'.log2foldchange\": 1,\n",
       " \"'zinc; 75 millimolar; p-delta-MT-Myc' vs 'zinc; 75 millimolar; empty vector'.p-value\": 1,\n",
       " \"'zinc; 75 millimolar; p-delta-MT-Myc' vs 'zinc; 75 millimolar; empty vector'.t-statistic\": 1,\n",
       " \"'zinc; 75 millimolar; p-delta-MT-Myc' vs 'zinc; 75 millimolar; empty vector'.log2foldchange\": 1,\n",
       " \"'zinc; 75 millimolar; p-delta-MT-Zip' vs 'zinc; 75 millimolar; empty vector'.p-value\": 1,\n",
       " \"'zinc; 75 millimolar; p-delta-MT-Zip' vs 'zinc; 75 millimolar; empty vector'.t-statistic\": 1,\n",
       " \"'zinc; 75 millimolar; p-delta-MT-Zip' vs 'zinc; 75 millimolar; empty vector'.log2foldchange\": 1,\n",
       " \"'IPI504' vs 'vehicle'.p-value\": 1,\n",
       " \"'IPI504' vs 'vehicle'.t-statistic\": 1,\n",
       " \"'IPI504' vs 'vehicle'.log2foldchange\": 1,\n",
       " \"'MiaPaCa2; AGR2 overexpressing vector' vs 'MiaPaCa2; empty vector'.p-value\": 1,\n",
       " \"'MiaPaCa2; AGR2 overexpressing vector' vs 'MiaPaCa2; empty vector'.t-statistic\": 1,\n",
       " \"'MiaPaCa2; AGR2 overexpressing vector' vs 'MiaPaCa2; empty vector'.log2foldchange\": 1,\n",
       " \"'transfected with AGR2 siRNA; FA6' vs 'transfected with non-targeting siRNA; FA6'.p-value\": 1,\n",
       " \"'transfected with AGR2 siRNA; FA6' vs 'transfected with non-targeting siRNA; FA6'.t-statistic\": 1,\n",
       " \"'transfected with AGR2 siRNA; FA6' vs 'transfected with non-targeting siRNA; FA6'.log2foldchange\": 1,\n",
       " \"'estrogen receptor negative tumor; ductal; tamoxifen' vs 'estrogen receptor negative tumor; ductal; placebo'.p-value\": 1,\n",
       " \"'estrogen receptor negative tumor; ductal; tamoxifen' vs 'estrogen receptor negative tumor; ductal; placebo'.t-statistic\": 1,\n",
       " \"'estrogen receptor negative tumor; ductal; tamoxifen' vs 'estrogen receptor negative tumor; ductal; placebo'.log2foldchange\": 1,\n",
       " \"'estrogen receptor positive tumor; ductal; tamoxifen' vs 'estrogen receptor positive tumor; ductal; placebo'.p-value\": 1,\n",
       " \"'estrogen receptor positive tumor; ductal; tamoxifen' vs 'estrogen receptor positive tumor; ductal; placebo'.t-statistic\": 1,\n",
       " \"'estrogen receptor positive tumor; ductal; tamoxifen' vs 'estrogen receptor positive tumor; ductal; placebo'.log2foldchange\": 1,\n",
       " \"'estrogen receptor positive tumor; lobular; tamoxifen' vs 'estrogen receptor positive tumor; lobular; placebo'.p-value\": 1,\n",
       " \"'estrogen receptor positive tumor; lobular; tamoxifen' vs 'estrogen receptor positive tumor; lobular; placebo'.t-statistic\": 1,\n",
       " \"'estrogen receptor positive tumor; lobular; tamoxifen' vs 'estrogen receptor positive tumor; lobular; placebo'.log2foldchange\": 1,\n",
       " \"'PKA RI-alpha over expression' vs 'wild type'.p-value\": 1,\n",
       " \"'PKA RI-alpha over expression' vs 'wild type'.t-statistic\": 1,\n",
       " \"'PKA RI-alpha over expression' vs 'wild type'.log2foldchange\": 1,\n",
       " \"'PKA RII-beta over expression' vs 'wild type'.p-value\": 1,\n",
       " \"'PKA RII-beta over expression' vs 'wild type'.t-statistic\": 1,\n",
       " \"'PKA RII-beta over expression' vs 'wild type'.log2foldchange\": 1,\n",
       " \"'tobacco smoke condensate 1 microgram per milliliter' vs 'control' in 'A549'.p-value\": 1,\n",
       " \"'tobacco smoke condensate 1 microgram per milliliter' vs 'control' in 'A549'.t-statistic\": 1,\n",
       " \"'tobacco smoke condensate 1 microgram per milliliter' vs 'control' in 'A549'.log2foldchange\": 1,\n",
       " \"'tobacco smoke condensate 3 microgram per milliliter' vs 'control' in 'A549'.p-value\": 1,\n",
       " \"'tobacco smoke condensate 3 microgram per milliliter' vs 'control' in 'A549'.t-statistic\": 1,\n",
       " \"'tobacco smoke condensate 3 microgram per milliliter' vs 'control' in 'A549'.log2foldchange\": 1,\n",
       " \"'tobacco smoke condensate 0.6 microgram per milliliter' vs 'control' in 'A549'.p-value\": 1,\n",
       " \"'tobacco smoke condensate 0.6 microgram per milliliter' vs 'control' in 'A549'.t-statistic\": 1,\n",
       " \"'tobacco smoke condensate 0.6 microgram per milliliter' vs 'control' in 'A549'.log2foldchange\": 1,\n",
       " \"'tobacco smoke condensate 1 microgram per milliliter' vs 'control' in 'Calu-6'.p-value\": 1,\n",
       " \"'tobacco smoke condensate 1 microgram per milliliter' vs 'control' in 'Calu-6'.t-statistic\": 1,\n",
       " \"'tobacco smoke condensate 1 microgram per milliliter' vs 'control' in 'Calu-6'.log2foldchange\": 1,\n",
       " \"'tobacco smoke condensate 3 microgram per milliliter' vs 'control' in 'Calu-6'.p-value\": 1,\n",
       " \"'tobacco smoke condensate 3 microgram per milliliter' vs 'control' in 'Calu-6'.t-statistic\": 1,\n",
       " \"'tobacco smoke condensate 3 microgram per milliliter' vs 'control' in 'Calu-6'.log2foldchange\": 1,\n",
       " \"'tobacco smoke condensate 0.6 microgram per milliliter' vs 'control' in 'Calu-6'.p-value\": 1,\n",
       " \"'tobacco smoke condensate 0.6 microgram per milliliter' vs 'control' in 'Calu-6'.t-statistic\": 1,\n",
       " \"'tobacco smoke condensate 0.6 microgram per milliliter' vs 'control' in 'Calu-6'.log2foldchange\": 1,\n",
       " \"'CXCR4 shRNA I' vs 'none'.p-value\": 1,\n",
       " \"'CXCR4 shRNA I' vs 'none'.t-statistic\": 1,\n",
       " \"'CXCR4 shRNA I' vs 'none'.log2foldchange\": 1,\n",
       " \"'CXCR4 shRNA II' vs 'none'.p-value\": 1,\n",
       " \"'CXCR4 shRNA II' vs 'none'.t-statistic\": 1,\n",
       " \"'CXCR4 shRNA II' vs 'none'.log2foldchange\": 1,\n",
       " \"'CXCR4 shRNA I' vs 'scrambled RNA'.p-value\": 1,\n",
       " \"'CXCR4 shRNA I' vs 'scrambled RNA'.t-statistic\": 1,\n",
       " \"'CXCR4 shRNA I' vs 'scrambled RNA'.log2foldchange\": 1,\n",
       " \"'CXCR4 shRNA II' vs 'scrambled RNA'.p-value\": 1,\n",
       " \"'CXCR4 shRNA II' vs 'scrambled RNA'.t-statistic\": 1,\n",
       " \"'CXCR4 shRNA II' vs 'scrambled RNA'.log2foldchange\": 1,\n",
       " \"'pancreatic cancer' vs 'healthy'.p-value\": 1,\n",
       " \"'pancreatic cancer' vs 'healthy'.t-statistic\": 1,\n",
       " \"'pancreatic cancer' vs 'healthy'.log2foldchange\": 1,\n",
       " \"'overexpression of JAG1' vs 'control'.p-value\": 1,\n",
       " \"'overexpression of JAG1' vs 'control'.t-statistic\": 1,\n",
       " \"'overexpression of JAG1' vs 'control'.log2foldchange\": 1,\n",
       " \"'Kidney Oncocytoma' vs 'normal'.p-value\": 1,\n",
       " \"'Kidney Oncocytoma' vs 'normal'.t-statistic\": 1,\n",
       " \"'Kidney Oncocytoma' vs 'normal'.log2foldchange\": 1,\n",
       " \"'chromophobe renal cell carcinoma' vs 'normal'.p-value\": 1,\n",
       " \"'chromophobe renal cell carcinoma' vs 'normal'.t-statistic\": 1,\n",
       " \"'chromophobe renal cell carcinoma' vs 'normal'.log2foldchange\": 1,\n",
       " \"'clear cell renal carcinoma' vs 'normal'.p-value\": 1,\n",
       " \"'clear cell renal carcinoma' vs 'normal'.t-statistic\": 1,\n",
       " \"'clear cell renal carcinoma' vs 'normal'.log2foldchange\": 1,\n",
       " \"'papillary renal cell carcinoma' vs 'normal'.p-value\": 1,\n",
       " \"'papillary renal cell carcinoma' vs 'normal'.t-statistic\": 1,\n",
       " \"'papillary renal cell carcinoma' vs 'normal'.log2foldchange\": 1,\n",
       " \"'transitional cell carcinoma of kidney' vs 'normal'.p-value\": 1,\n",
       " \"'transitional cell carcinoma of kidney' vs 'normal'.t-statistic\": 1,\n",
       " \"'transitional cell carcinoma of kidney' vs 'normal'.log2foldchange\": 1,\n",
       " \"'SDF1; 400 nanogram per milliliter' vs 'none' in 'expressing CXCR4'.p-value\": 1,\n",
       " \"'SDF1; 400 nanogram per milliliter' vs 'none' in 'expressing CXCR4'.t-statistic\": 1,\n",
       " \"'SDF1; 400 nanogram per milliliter' vs 'none' in 'expressing CXCR4'.log2foldchange\": 1,\n",
       " \"'expressing CXCR4' vs 'not expressing CXCR4'.p-value\": 1,\n",
       " \"'expressing CXCR4' vs 'not expressing CXCR4'.t-statistic\": 1,\n",
       " \"'expressing CXCR4' vs 'not expressing CXCR4'.log2foldchange\": 1,\n",
       " \"'resistant to methotrexate' vs 'sensitive to methotrexate'.p-value\": 4,\n",
       " \"'resistant to methotrexate' vs 'sensitive to methotrexate'.t-statistic\": 4,\n",
       " \"'resistant to methotrexate' vs 'sensitive to methotrexate'.log2foldchange\": 4,\n",
       " \"'atypical ductal hyperplasia' vs 'histologically normal'.p-value\": 1,\n",
       " \"'atypical ductal hyperplasia' vs 'histologically normal'.t-statistic\": 1,\n",
       " \"'atypical ductal hyperplasia' vs 'histologically normal'.log2foldchange\": 1,\n",
       " \"'ductal carcinoma in situ' vs 'histologically normal'.p-value\": 1,\n",
       " \"'ductal carcinoma in situ' vs 'histologically normal'.t-statistic\": 1,\n",
       " \"'ductal carcinoma in situ' vs 'histologically normal'.log2foldchange\": 1,\n",
       " \"'simple ductal hyperplasia' vs 'histologically normal'.p-value\": 1,\n",
       " \"'simple ductal hyperplasia' vs 'histologically normal'.t-statistic\": 1,\n",
       " \"'simple ductal hyperplasia' vs 'histologically normal'.log2foldchange\": 1,\n",
       " \"'3D cell culture' vs '2D cell culture' in 'A459'.p-value\": 1,\n",
       " \"'3D cell culture' vs '2D cell culture' in 'A459'.t-statistic\": 1,\n",
       " \"'3D cell culture' vs '2D cell culture' in 'A459'.log2foldchange\": 1,\n",
       " \"'3D cell culture' vs '2D cell culture' in 'UT-15'.p-value\": 1,\n",
       " \"'3D cell culture' vs '2D cell culture' in 'UT-15'.t-statistic\": 1,\n",
       " \"'3D cell culture' vs '2D cell culture' in 'UT-15'.log2foldchange\": 1,\n",
       " \"'Stat3 knockdown' vs 'control' in 'CWR22Rv1'.p-value\": 1,\n",
       " \"'Stat3 knockdown' vs 'control' in 'CWR22Rv1'.t-statistic\": 1,\n",
       " \"'Stat3 knockdown' vs 'control' in 'CWR22Rv1'.log2foldchange\": 1,\n",
       " \"'Stat5a/b knockdown' vs 'control' in 'CWR22Rv1'.p-value\": 1,\n",
       " \"'Stat5a/b knockdown' vs 'control' in 'CWR22Rv1'.t-statistic\": 1,\n",
       " \"'Stat5a/b knockdown' vs 'control' in 'CWR22Rv1'.log2foldchange\": 1,\n",
       " \"'Stat3 knockdown' vs 'control' in 'DU145'.p-value\": 1,\n",
       " \"'Stat3 knockdown' vs 'control' in 'DU145'.t-statistic\": 1,\n",
       " \"'Stat3 knockdown' vs 'control' in 'DU145'.log2foldchange\": 1,\n",
       " \"'Stat5a/b knockdown' vs 'control' in 'DU145'.p-value\": 1,\n",
       " \"'Stat5a/b knockdown' vs 'control' in 'DU145'.t-statistic\": 1,\n",
       " \"'Stat5a/b knockdown' vs 'control' in 'DU145'.log2foldchange\": 1,\n",
       " \"'side population cell' vs 'non-side population cell'.p-value\": 1,\n",
       " \"'side population cell' vs 'non-side population cell'.t-statistic\": 1,\n",
       " \"'side population cell' vs 'non-side population cell'.log2foldchange\": 1,\n",
       " \"'non-small cell lung cancer' vs 'normal'.p-value\": 1,\n",
       " \"'non-small cell lung cancer' vs 'normal'.t-statistic\": 1,\n",
       " \"'non-small cell lung cancer' vs 'normal'.log2foldchange\": 1,\n",
       " \"'resistant to BMS-554417' vs 'sensitive to BMS-554417'.p-value\": 1,\n",
       " \"'resistant to BMS-554417' vs 'sensitive to BMS-554417'.t-statistic\": 1,\n",
       " \"'resistant to BMS-554417' vs 'sensitive to BMS-554417'.log2foldchange\": 1,\n",
       " \"'S100P overexpressing' vs 'control'.p-value\": 1,\n",
       " \"'S100P overexpressing' vs 'control'.t-statistic\": 1,\n",
       " \"'S100P overexpressing' vs 'control'.log2foldchange\": 1,\n",
       " \"'cancer tissue' vs 'surrounding noncancerous tissue' in 'hepatitis B virus induced hepatocellular carcinoma'.p-value\": 1,\n",
       " \"'cancer tissue' vs 'surrounding noncancerous tissue' in 'hepatitis B virus induced hepatocellular carcinoma'.t-statistic\": 1,\n",
       " \"'cancer tissue' vs 'surrounding noncancerous tissue' in 'hepatitis B virus induced hepatocellular carcinoma'.log2foldchange\": 1,\n",
       " \"'cancer tissue' vs 'surrounding noncancerous tissue' in 'hepatitis C virus induced hepatocellular carcinoma'.p-value\": 1,\n",
       " \"'cancer tissue' vs 'surrounding noncancerous tissue' in 'hepatitis C virus induced hepatocellular carcinoma'.t-statistic\": 1,\n",
       " \"'cancer tissue' vs 'surrounding noncancerous tissue' in 'hepatitis C virus induced hepatocellular carcinoma'.log2foldchange\": 1,\n",
       " \"'si221' vs 'control'.p-value\": 1,\n",
       " \"'si221' vs 'control'.t-statistic\": 1,\n",
       " \"'si221' vs 'control'.log2foldchange\": 1,\n",
       " \"'si222' vs 'control'.p-value\": 1,\n",
       " \"'si222' vs 'control'.t-statistic\": 1,\n",
       " \"'si222' vs 'control'.log2foldchange\": 1,\n",
       " \"'primary tumor' vs 'adjacent normal tissue'.p-value\": 2,\n",
       " \"'primary tumor' vs 'adjacent normal tissue'.t-statistic\": 2,\n",
       " \"'primary tumor' vs 'adjacent normal tissue'.log2foldchange\": 2,\n",
       " \"'gastric carcinoma; tumor' vs 'gastric carcinoma; adjacent normal tissue'.p-value\": 1,\n",
       " \"'gastric carcinoma; tumor' vs 'gastric carcinoma; adjacent normal tissue'.t-statistic\": 1,\n",
       " \"'gastric carcinoma; tumor' vs 'gastric carcinoma; adjacent normal tissue'.log2foldchange\": 1,\n",
       " \"'gastric carcinoma; adjacent normal tissue' vs 'normal; normal'.p-value\": 1,\n",
       " \"'gastric carcinoma; adjacent normal tissue' vs 'normal; normal'.t-statistic\": 1,\n",
       " \"'gastric carcinoma; adjacent normal tissue' vs 'normal; normal'.log2foldchange\": 1,\n",
       " \"'gastric carcinoma; tumor' vs 'normal; normal'.p-value\": 1,\n",
       " \"'gastric carcinoma; tumor' vs 'normal; normal'.t-statistic\": 1,\n",
       " \"'gastric carcinoma; tumor' vs 'normal; normal'.log2foldchange\": 1,\n",
       " \"'GDC-0941 1 millimolar' vs 'none'.p-value\": 1,\n",
       " \"'GDC-0941 1 millimolar' vs 'none'.t-statistic\": 1,\n",
       " \"'GDC-0941 1 millimolar' vs 'none'.log2foldchange\": 1,\n",
       " \"'transfection with miR-Dmimic' vs 'control'.p-value\": 1,\n",
       " \"'transfection with miR-Dmimic' vs 'control'.t-statistic\": 1,\n",
       " \"'transfection with miR-Dmimic' vs 'control'.log2foldchange\": 1,\n",
       " \"'transfection with miR-Qmimic' vs 'control'.p-value\": 1,\n",
       " \"'transfection with miR-Qmimic' vs 'control'.t-statistic\": 1,\n",
       " \"'transfection with miR-Qmimic' vs 'control'.log2foldchange\": 1,\n",
       " \"'50 micromolar motexafin gadolinium' vs '5 percent mannitol' at '4 hour'.p-value\": 1,\n",
       " \"'50 micromolar motexafin gadolinium' vs '5 percent mannitol' at '4 hour'.t-statistic\": 1,\n",
       " \"'50 micromolar motexafin gadolinium' vs '5 percent mannitol' at '4 hour'.log2foldchange\": 1,\n",
       " \"'50 micromolar motexafin gadolinium' vs '5 percent mannitol' at '12 hour'.p-value\": 1,\n",
       " \"'50 micromolar motexafin gadolinium' vs '5 percent mannitol' at '12 hour'.t-statistic\": 1,\n",
       " \"'50 micromolar motexafin gadolinium' vs '5 percent mannitol' at '12 hour'.log2foldchange\": 1,\n",
       " \"'50 micromolar motexafin gadolinium' vs '5 percent mannitol' at '24 hour'.p-value\": 1,\n",
       " \"'50 micromolar motexafin gadolinium' vs '5 percent mannitol' at '24 hour'.t-statistic\": 1,\n",
       " \"'50 micromolar motexafin gadolinium' vs '5 percent mannitol' at '24 hour'.log2foldchange\": 1,\n",
       " \"'estrogen receptor positive' vs 'estrogen receptor negative'.p-value\": 1,\n",
       " \"'estrogen receptor positive' vs 'estrogen receptor negative'.t-statistic\": 1,\n",
       " \"'estrogen receptor positive' vs 'estrogen receptor negative'.log2foldchange\": 1,\n",
       " \"'overexpression of HO-1' vs 'control' in '0 nanogram per milliliter; tumor necrosis factor'.p-value\": 1,\n",
       " \"'overexpression of HO-1' vs 'control' in '0 nanogram per milliliter; tumor necrosis factor'.t-statistic\": 1,\n",
       " \"'overexpression of HO-1' vs 'control' in '0 nanogram per milliliter; tumor necrosis factor'.log2foldchange\": 1,\n",
       " \"'overexpression of HO-1' vs 'control' in '30 nanogram per milliliter; tumor necrosis factor'.p-value\": 1,\n",
       " \"'overexpression of HO-1' vs 'control' in '30 nanogram per milliliter; tumor necrosis factor'.t-statistic\": 1,\n",
       " \"'overexpression of HO-1' vs 'control' in '30 nanogram per milliliter; tumor necrosis factor'.log2foldchange\": 1,\n",
       " \"'prostate carcinoma' vs 'normal'.p-value\": 1,\n",
       " \"'prostate carcinoma' vs 'normal'.log2foldchange\": 1,\n",
       " \"'fulvestrant' vs 'ethanol' in 'HCC-1428/LTED'.p-value\": 1,\n",
       " \"'fulvestrant' vs 'ethanol' in 'HCC-1428/LTED'.t-statistic\": 1,\n",
       " \"'fulvestrant' vs 'ethanol' in 'HCC-1428/LTED'.log2foldchange\": 1,\n",
       " \"'fulvestrant' vs 'ethanol' in 'MCF-7/LTED'.p-value\": 1,\n",
       " \"'fulvestrant' vs 'ethanol' in 'MCF-7/LTED'.t-statistic\": 1,\n",
       " \"'fulvestrant' vs 'ethanol' in 'MCF-7/LTED'.log2foldchange\": 1,\n",
       " \"'estrogen' vs 'placebo' in 'estrogen receptor negative'.p-value\": 1,\n",
       " \"'estrogen' vs 'placebo' in 'estrogen receptor negative'.t-statistic\": 1,\n",
       " \"'estrogen' vs 'placebo' in 'estrogen receptor negative'.log2foldchange\": 1,\n",
       " \"'estrogen' vs 'placebo' in 'estrogen receptor positive'.p-value\": 1,\n",
       " \"'estrogen' vs 'placebo' in 'estrogen receptor positive'.t-statistic\": 1,\n",
       " \"'estrogen' vs 'placebo' in 'estrogen receptor positive'.log2foldchange\": 1,\n",
       " \"'phorbol 13-acetate 12-myristate; 1 micromolar' vs 'none' in 'AsPC-1'.p-value\": 1,\n",
       " \"'phorbol 13-acetate 12-myristate; 1 micromolar' vs 'none' in 'AsPC-1'.t-statistic\": 1,\n",
       " \"'phorbol 13-acetate 12-myristate; 1 micromolar' vs 'none' in 'AsPC-1'.log2foldchange\": 1,\n",
       " \"'phorbol 13-acetate 12-myristate; 1 micromolar' vs 'none' in 'BxPC-3'.p-value\": 1,\n",
       " \"'phorbol 13-acetate 12-myristate; 1 micromolar' vs 'none' in 'BxPC-3'.t-statistic\": 1,\n",
       " \"'phorbol 13-acetate 12-myristate; 1 micromolar' vs 'none' in 'BxPC-3'.log2foldchange\": 1,\n",
       " \"'glioblastoma' vs 'control'.p-value\": 1,\n",
       " \"'glioblastoma' vs 'control'.t-statistic\": 1,\n",
       " \"'glioblastoma' vs 'control'.log2foldchange\": 1,\n",
       " \"'resveratrol; 150 millimolar' vs 'vehicle; '.p-value\": 1,\n",
       " \"'resveratrol; 150 millimolar' vs 'vehicle; '.t-statistic\": 1,\n",
       " \"'resveratrol; 150 millimolar' vs 'vehicle; '.log2foldchange\": 1,\n",
       " \"'resveratrol; 250 millimolar' vs 'vehicle; '.p-value\": 1,\n",
       " \"'resveratrol; 250 millimolar' vs 'vehicle; '.t-statistic\": 1,\n",
       " \"'resveratrol; 250 millimolar' vs 'vehicle; '.log2foldchange\": 1,\n",
       " \"'MTDH knockdown' vs 'control'.p-value\": 1,\n",
       " \"'MTDH knockdown' vs 'control'.t-statistic\": 1,\n",
       " \"'MTDH knockdown' vs 'control'.log2foldchange\": 1,\n",
       " \"'triple negative breast cancer tumor' vs 'non-triple negative breast cancer tumor'.p-value\": 1,\n",
       " \"'triple negative breast cancer tumor' vs 'non-triple negative breast cancer tumor'.t-statistic\": 1,\n",
       " \"'triple negative breast cancer tumor' vs 'non-triple negative breast cancer tumor'.log2foldchange\": 1,\n",
       " \"'contralateral site; adenocarcinoma' vs 'contralateral site; control'.p-value\": 1,\n",
       " \"'contralateral site; adenocarcinoma' vs 'contralateral site; control'.t-statistic\": 1,\n",
       " \"'contralateral site; adenocarcinoma' vs 'contralateral site; control'.log2foldchange\": 1,\n",
       " \"'contralateral site; squamous cell carcinoma' vs 'contralateral site; control'.p-value\": 1,\n",
       " \"'contralateral site; squamous cell carcinoma' vs 'contralateral site; control'.t-statistic\": 1,\n",
       " \"'contralateral site; squamous cell carcinoma' vs 'contralateral site; control'.log2foldchange\": 1,\n",
       " \"'nodule site; adenocarcinoma' vs 'nodule site; control'.p-value\": 1,\n",
       " \"'nodule site; adenocarcinoma' vs 'nodule site; control'.t-statistic\": 1,\n",
       " \"'nodule site; adenocarcinoma' vs 'nodule site; control'.log2foldchange\": 1,\n",
       " \"'nodule site; squamous cell carcinoma' vs 'nodule site; control'.p-value\": 1,\n",
       " \"'nodule site; squamous cell carcinoma' vs 'nodule site; control'.t-statistic\": 1,\n",
       " \"'nodule site; squamous cell carcinoma' vs 'nodule site; control'.log2foldchange\": 1,\n",
       " \"'10 nanomolar 17beta-estradiol' vs 'vehicle' in 'SUM149PT'.p-value\": 1,\n",
       " \"'10 nanomolar 17beta-estradiol' vs 'vehicle' in 'SUM149PT'.t-statistic\": 1,\n",
       " \"'10 nanomolar 17beta-estradiol' vs 'vehicle' in 'SUM149PT'.log2foldchange\": 1,\n",
       " \"'10 nanomolar 17beta-estradiol and 7.5 micromolar CG-1521' vs 'vehicle' in 'SUM149PT'.p-value\": 1,\n",
       " \"'10 nanomolar 17beta-estradiol and 7.5 micromolar CG-1521' vs 'vehicle' in 'SUM149PT'.t-statistic\": 1,\n",
       " \"'10 nanomolar 17beta-estradiol and 7.5 micromolar CG-1521' vs 'vehicle' in 'SUM149PT'.log2foldchange\": 1,\n",
       " \"'7.5 micromolar CG-1521' vs 'vehicle' in 'SUM149PT'.p-value\": 1,\n",
       " \"'7.5 micromolar CG-1521' vs 'vehicle' in 'SUM149PT'.t-statistic\": 1,\n",
       " \"'7.5 micromolar CG-1521' vs 'vehicle' in 'SUM149PT'.log2foldchange\": 1,\n",
       " \"'10 nanomolar 17beta-estradiol' vs 'vehicle' in 'SUM190PT'.p-value\": 1,\n",
       " \"'10 nanomolar 17beta-estradiol' vs 'vehicle' in 'SUM190PT'.t-statistic\": 1,\n",
       " \"'10 nanomolar 17beta-estradiol' vs 'vehicle' in 'SUM190PT'.log2foldchange\": 1,\n",
       " \"'10 nanomolar 17beta-estradiol and 5 micromolar CG-1521' vs 'vehicle' in 'SUM190PT'.p-value\": 1,\n",
       " \"'10 nanomolar 17beta-estradiol and 5 micromolar CG-1521' vs 'vehicle' in 'SUM190PT'.t-statistic\": 1,\n",
       " \"'10 nanomolar 17beta-estradiol and 5 micromolar CG-1521' vs 'vehicle' in 'SUM190PT'.log2foldchange\": 1,\n",
       " \"'5 micromolar CG-1521' vs 'vehicle' in 'SUM190PT'.p-value\": 1,\n",
       " \"'5 micromolar CG-1521' vs 'vehicle' in 'SUM190PT'.t-statistic\": 1,\n",
       " \"'5 micromolar CG-1521' vs 'vehicle' in 'SUM190PT'.log2foldchange\": 1,\n",
       " \"'long-term survival' vs 'short-term survival' in 'adenocarcinoma'.p-value\": 1,\n",
       " \"'long-term survival' vs 'short-term survival' in 'adenocarcinoma'.t-statistic\": 1,\n",
       " \"'long-term survival' vs 'short-term survival' in 'adenocarcinoma'.log2foldchange\": 1,\n",
       " \"'long-term survival' vs 'short-term survival' in 'large cell carcinoma'.p-value\": 1,\n",
       " \"'long-term survival' vs 'short-term survival' in 'large cell carcinoma'.t-statistic\": 1,\n",
       " \"'long-term survival' vs 'short-term survival' in 'large cell carcinoma'.log2foldchange\": 1,\n",
       " \"'long-term survival' vs 'short-term survival' in 'squamous cell carcinoma'.p-value\": 1,\n",
       " \"'long-term survival' vs 'short-term survival' in 'squamous cell carcinoma'.t-statistic\": 1,\n",
       " \"'long-term survival' vs 'short-term survival' in 'squamous cell carcinoma'.log2foldchange\": 1,\n",
       " \"'MPS-1 shRNA' vs 'control shRNA'.p-value\": 1,\n",
       " \"'MPS-1 shRNA' vs 'control shRNA'.t-statistic\": 1,\n",
       " \"'MPS-1 shRNA' vs 'control shRNA'.log2foldchange\": 1,\n",
       " \"'tumor tissue' vs 'adjacent normal tissue' in 'gastric cardia carcinoma'.p-value\": 1,\n",
       " \"'tumor tissue' vs 'adjacent normal tissue' in 'gastric cardia carcinoma'.t-statistic\": 1,\n",
       " \"'tumor tissue' vs 'adjacent normal tissue' in 'gastric cardia carcinoma'.log2foldchange\": 1,\n",
       " \"'tumor tissue' vs 'adjacent normal tissue' in 'gastric non-cardia carcinoma'.p-value\": 1,\n",
       " \"'tumor tissue' vs 'adjacent normal tissue' in 'gastric non-cardia carcinoma'.t-statistic\": 1,\n",
       " \"'tumor tissue' vs 'adjacent normal tissue' in 'gastric non-cardia carcinoma'.log2foldchange\": 1,\n",
       " \"'shRNA22' vs 'control shRNA'.p-value\": 1,\n",
       " \"'shRNA22' vs 'control shRNA'.t-statistic\": 1,\n",
       " \"'shRNA22' vs 'control shRNA'.log2foldchange\": 1,\n",
       " \"'LSD1 knockdown' vs 'control'.p-value\": 1,\n",
       " \"'LSD1 knockdown' vs 'control'.t-statistic\": 1,\n",
       " \"'LSD1 knockdown' vs 'control'.log2foldchange\": 1,\n",
       " \"'hypoxia' vs 'normoxia' in 'adenocarcinoma'.p-value\": 1,\n",
       " \"'hypoxia' vs 'normoxia' in 'adenocarcinoma'.t-statistic\": 1,\n",
       " \"'hypoxia' vs 'normoxia' in 'adenocarcinoma'.log2foldchange\": 1,\n",
       " \"'hypoxia' vs 'normoxia' in 'squamous cell carcinoma'.p-value\": 1,\n",
       " \"'hypoxia' vs 'normoxia' in 'squamous cell carcinoma'.t-statistic\": 1,\n",
       " \"'hypoxia' vs 'normoxia' in 'squamous cell carcinoma'.log2foldchange\": 1,\n",
       " \"'U0126' vs 'none' in 'HT1080' at '6 hour'.p-value\": 1,\n",
       " \"'U0126' vs 'none' in 'HT1080' at '6 hour'.t-statistic\": 1,\n",
       " \"'U0126' vs 'none' in 'HT1080' at '6 hour'.log2foldchange\": 1,\n",
       " \"'interferon-alpha + U0126' vs 'none' in 'HT1080' at '6 hour'.p-value\": 1,\n",
       " \"'interferon-alpha + U0126' vs 'none' in 'HT1080' at '6 hour'.t-statistic\": 1,\n",
       " \"'interferon-alpha + U0126' vs 'none' in 'HT1080' at '6 hour'.log2foldchange\": 1,\n",
       " \"'interferon-alpha' vs 'none' in 'HT1080' at '6 hour'.p-value\": 1,\n",
       " \"'interferon-alpha' vs 'none' in 'HT1080' at '6 hour'.t-statistic\": 1,\n",
       " \"'interferon-alpha' vs 'none' in 'HT1080' at '6 hour'.log2foldchange\": 1,\n",
       " \"'U0126' vs 'none' in 'HT1080' at '12 hour'.p-value\": 1,\n",
       " \"'U0126' vs 'none' in 'HT1080' at '12 hour'.t-statistic\": 1,\n",
       " \"'U0126' vs 'none' in 'HT1080' at '12 hour'.log2foldchange\": 1,\n",
       " \"'interferon-alpha + U0126' vs 'none' in 'HT1080' at '12 hour'.p-value\": 1,\n",
       " \"'interferon-alpha + U0126' vs 'none' in 'HT1080' at '12 hour'.t-statistic\": 1,\n",
       " \"'interferon-alpha + U0126' vs 'none' in 'HT1080' at '12 hour'.log2foldchange\": 1,\n",
       " \"'interferon-alpha' vs 'none' in 'HT1080' at '12 hour'.p-value\": 1,\n",
       " \"'interferon-alpha' vs 'none' in 'HT1080' at '12 hour'.t-statistic\": 1,\n",
       " \"'interferon-alpha' vs 'none' in 'HT1080' at '12 hour'.log2foldchange\": 1,\n",
       " \"'interferon-alpha' vs 'none' in 'SKOV3' at '6 hour'.p-value\": 1,\n",
       " \"'interferon-alpha' vs 'none' in 'SKOV3' at '6 hour'.t-statistic\": 1,\n",
       " \"'interferon-alpha' vs 'none' in 'SKOV3' at '6 hour'.log2foldchange\": 1,\n",
       " \"'invasive ductal carcinoma' vs 'normal'.p-value\": 1,\n",
       " \"'invasive ductal carcinoma' vs 'normal'.t-statistic\": 1,\n",
       " \"'invasive ductal carcinoma' vs 'normal'.log2foldchange\": 1,\n",
       " \"'normal epithelial cell; pregnancy associate breast cancer patient' vs 'normal epithelial cell; non-pregnancy associate breast cancer patient'.p-value\": 1,\n",
       " \"'normal epithelial cell; pregnancy associate breast cancer patient' vs 'normal epithelial cell; non-pregnancy associate breast cancer patient'.t-statistic\": 1,\n",
       " \"'normal epithelial cell; pregnancy associate breast cancer patient' vs 'normal epithelial cell; non-pregnancy associate breast cancer patient'.log2foldchange\": 1,\n",
       " \"'tumor associated stroma cell; pregnancy associate breast cancer patient' vs 'tumor associated stroma cell; non-pregnancy associate breast cancer patient'.p-value\": 1,\n",
       " \"'tumor associated stroma cell; pregnancy associate breast cancer patient' vs 'tumor associated stroma cell; non-pregnancy associate breast cancer patient'.t-statistic\": 1,\n",
       " \"'tumor associated stroma cell; pregnancy associate breast cancer patient' vs 'tumor associated stroma cell; non-pregnancy associate breast cancer patient'.log2foldchange\": 1,\n",
       " \"'tumor epithelial cell; pregnancy associate breast cancer patient' vs 'tumor epithelial cell; non-pregnancy associate breast cancer patient'.p-value\": 1,\n",
       " \"'tumor epithelial cell; pregnancy associate breast cancer patient' vs 'tumor epithelial cell; non-pregnancy associate breast cancer patient'.t-statistic\": 1,\n",
       " \"'tumor epithelial cell; pregnancy associate breast cancer patient' vs 'tumor epithelial cell; non-pregnancy associate breast cancer patient'.log2foldchange\": 1,\n",
       " \"'non small cell lung cancer; sensitive to erlotinib' vs 'non small cell lung cancer; non-sensitive to erlotinib'.p-value\": 1,\n",
       " \"'non small cell lung cancer; sensitive to erlotinib' vs 'non small cell lung cancer; non-sensitive to erlotinib'.t-statistic\": 1,\n",
       " \"'non small cell lung cancer; sensitive to erlotinib' vs 'non small cell lung cancer; non-sensitive to erlotinib'.log2foldchange\": 1,\n",
       " \"'lung cancer' vs 'normal'.p-value\": 1,\n",
       " \"'lung cancer' vs 'normal'.t-statistic\": 1,\n",
       " \"'lung cancer' vs 'normal'.log2foldchange\": 1,\n",
       " \"'S2N; tumorigenic; monolayer' vs 'S2; non-tumorigenic; monolayer'.p-value\": 1,\n",
       " \"'S2N; tumorigenic; monolayer' vs 'S2; non-tumorigenic; monolayer'.t-statistic\": 1,\n",
       " \"'S2N; tumorigenic; monolayer' vs 'S2; non-tumorigenic; monolayer'.log2foldchange\": 1,\n",
       " \"'S2N; tumorigenic; spheres' vs 'S2; non-tumorigenic; spheres'.p-value\": 1,\n",
       " \"'S2N; tumorigenic; spheres' vs 'S2; non-tumorigenic; spheres'.t-statistic\": 1,\n",
       " \"'S2N; tumorigenic; spheres' vs 'S2; non-tumorigenic; spheres'.log2foldchange\": 1,\n",
       " \"'SAH-BCL9B peptides' vs 'vehicle'.p-value\": 1,\n",
       " \"'SAH-BCL9B peptides' vs 'vehicle'.t-statistic\": 1,\n",
       " \"'SAH-BCL9B peptides' vs 'vehicle'.log2foldchange\": 1,\n",
       " \"'primary prostate cancer' vs 'benign prostate tumor'.p-value\": 1,\n",
       " \"'primary prostate cancer' vs 'benign prostate tumor'.t-statistic\": 1,\n",
       " \"'primary prostate cancer' vs 'benign prostate tumor'.log2foldchange\": 1,\n",
       " \"'metastatic prostate cancer' vs 'benign prostate tumor'.p-value\": 1,\n",
       " \"'metastatic prostate cancer' vs 'benign prostate tumor'.t-statistic\": 1,\n",
       " \"'metastatic prostate cancer' vs 'benign prostate tumor'.log2foldchange\": 1,\n",
       " \"'tomato leaves extract' at '48 hour' vs 'untreated' at '0 hour'.p-value\": 1,\n",
       " \"'tomato leaves extract' at '48 hour' vs 'untreated' at '0 hour'.t-statistic\": 1,\n",
       " \"'tomato leaves extract' at '48 hour' vs 'untreated' at '0 hour'.log2foldchange\": 1,\n",
       " \"'DU-145; converted to docetaxel resistant cells' vs 'DU-145; none'.p-value\": 1,\n",
       " \"'DU-145; converted to docetaxel resistant cells' vs 'DU-145; none'.t-statistic\": 1,\n",
       " \"'DU-145; converted to docetaxel resistant cells' vs 'DU-145; none'.log2foldchange\": 1,\n",
       " \"'PC3; converted to docetaxel resistant cells' vs 'PC3; none'.p-value\": 1,\n",
       " \"'PC3; converted to docetaxel resistant cells' vs 'PC3; none'.t-statistic\": 1,\n",
       " \"'PC3; converted to docetaxel resistant cells' vs 'PC3; none'.log2foldchange\": 1,\n",
       " \"'depleted of HIF1a and HIF2a' vs 'control'.p-value\": 1,\n",
       " \"'depleted of HIF1a and HIF2a' vs 'control'.t-statistic\": 1,\n",
       " \"'depleted of HIF1a and HIF2a' vs 'control'.log2foldchange\": 1,\n",
       " \"'overexpressing Sharp1' vs 'control'.p-value\": 1,\n",
       " \"'overexpressing Sharp1' vs 'control'.t-statistic\": 1,\n",
       " \"'overexpressing Sharp1' vs 'control'.log2foldchange\": 1,\n",
       " \"'SHP2 knockdown with miR1' vs 'control'.p-value\": 1,\n",
       " \"'SHP2 knockdown with miR1' vs 'control'.t-statistic\": 1,\n",
       " \"'SHP2 knockdown with miR1' vs 'control'.log2foldchange\": 1,\n",
       " \"'SHP2 knockdown with miR2' vs 'control'.p-value\": 1,\n",
       " \"'SHP2 knockdown with miR2' vs 'control'.t-statistic\": 1,\n",
       " \"'SHP2 knockdown with miR2' vs 'control'.log2foldchange\": 1,\n",
       " \"'32 degree celsius; p53 status on' vs '37 degree celsius; p53 status off' in 'BT474'.p-value\": 1,\n",
       " \"'32 degree celsius; p53 status on' vs '37 degree celsius; p53 status off' in 'BT474'.t-statistic\": 1,\n",
       " \"'32 degree celsius; p53 status on' vs '37 degree celsius; p53 status off' in 'BT474'.log2foldchange\": 1,\n",
       " \"'32 degree celsius; p53 status on' vs '37 degree celsius; p53 status off' in 'IPH-926'.p-value\": 1,\n",
       " \"'32 degree celsius; p53 status on' vs '37 degree celsius; p53 status off' in 'IPH-926'.t-statistic\": 1,\n",
       " \"'32 degree celsius; p53 status on' vs '37 degree celsius; p53 status off' in 'IPH-926'.log2foldchange\": 1,\n",
       " \"'32 degree celsius; p53 status on' vs '37 degree celsius; p53 status off' in 'MCF-7'.p-value\": 1,\n",
       " \"'32 degree celsius; p53 status on' vs '37 degree celsius; p53 status off' in 'MCF-7'.t-statistic\": 1,\n",
       " \"'32 degree celsius; p53 status on' vs '37 degree celsius; p53 status off' in 'MCF-7'.log2foldchange\": 1,\n",
       " \"'estrogen receptor beta activator' vs 'control' in 'breast carcinoma'.p-value\": 1,\n",
       " \"'estrogen receptor beta activator' vs 'control' in 'breast carcinoma'.t-statistic\": 1,\n",
       " \"'estrogen receptor beta activator' vs 'control' in 'breast carcinoma'.log2foldchange\": 1,\n",
       " \"'estrogen receptor beta inhibitor' vs 'control' in 'breast carcinoma'.p-value\": 1,\n",
       " \"'estrogen receptor beta inhibitor' vs 'control' in 'breast carcinoma'.t-statistic\": 1,\n",
       " \"'estrogen receptor beta inhibitor' vs 'control' in 'breast carcinoma'.log2foldchange\": 1,\n",
       " \"'siRNA-HMGA1' vs 'control'.p-value\": 1,\n",
       " \"'siRNA-HMGA1' vs 'control'.t-statistic\": 1,\n",
       " \"'siRNA-HMGA1' vs 'control'.log2foldchange\": 1,\n",
       " \"'PAD2 knockdown' vs 'control'.p-value\": 1,\n",
       " \"'PAD2 knockdown' vs 'control'.t-statistic\": 1,\n",
       " \"'PAD2 knockdown' vs 'control'.log2foldchange\": 1,\n",
       " \"'estrogen receptor alpha siRNA knockdown' vs 'control'.p-value\": 1,\n",
       " \"'estrogen receptor alpha siRNA knockdown' vs 'control'.t-statistic\": 1,\n",
       " \"'estrogen receptor alpha siRNA knockdown' vs 'control'.log2foldchange\": 1,\n",
       " \"'VEGF165 overexpression' vs 'control' in 'breast adenocarcinoma'.p-value\": 1,\n",
       " \"'VEGF165 overexpression' vs 'control' in 'breast adenocarcinoma'.t-statistic\": 1,\n",
       " \"'VEGF165 overexpression' vs 'control' in 'breast adenocarcinoma'.log2foldchange\": 1,\n",
       " \"'VEGF189 overexpression' vs 'control' in 'breast adenocarcinoma'.p-value\": 1,\n",
       " \"'VEGF189 overexpression' vs 'control' in 'breast adenocarcinoma'.t-statistic\": 1,\n",
       " \"'VEGF189 overexpression' vs 'control' in 'breast adenocarcinoma'.log2foldchange\": 1,\n",
       " \"'CLF1' vs 'CLS1; co-culture with CAF to generate sphere'.p-value\": 1,\n",
       " \"'CLF1' vs 'CLS1; co-culture with CAF to generate sphere'.t-statistic\": 1,\n",
       " \"'CLF1' vs 'CLS1; co-culture with CAF to generate sphere'.log2foldchange\": 1,\n",
       " \"'CLS1; 6 passages' vs 'CLS1; co-culture with CAF to generate sphere'.p-value\": 1,\n",
       " \"'CLS1; 6 passages' vs 'CLS1; co-culture with CAF to generate sphere'.t-statistic\": 1,\n",
       " \"'CLS1; 6 passages' vs 'CLS1; co-culture with CAF to generate sphere'.log2foldchange\": 1,\n",
       " \"'breast cancer; breast' vs 'normal; breast'.p-value\": 1,\n",
       " \"'breast cancer; breast' vs 'normal; breast'.t-statistic\": 1,\n",
       " \"'breast cancer; breast' vs 'normal; breast'.log2foldchange\": 1,\n",
       " \"'FAM60A knockdown' vs 'scrambled siRNA'.p-value\": 1,\n",
       " \"'FAM60A knockdown' vs 'scrambled siRNA'.t-statistic\": 1,\n",
       " \"'FAM60A knockdown' vs 'scrambled siRNA'.log2foldchange\": 1,\n",
       " \"'SDS3 knockdown' vs 'scrambled siRNA'.p-value\": 1,\n",
       " \"'SDS3 knockdown' vs 'scrambled siRNA'.t-statistic\": 1,\n",
       " \"'SDS3 knockdown' vs 'scrambled siRNA'.log2foldchange\": 1,\n",
       " \"'10 micromolar doxorubicin' vs 'vehicle'.p-value\": 1,\n",
       " \"'10 micromolar doxorubicin' vs 'vehicle'.t-statistic\": 1,\n",
       " \"'10 micromolar doxorubicin' vs 'vehicle'.log2foldchange\": 1,\n",
       " \"'exogenous versican (VCAN)' vs 'none'.p-value\": 1,\n",
       " \"'exogenous versican (VCAN)' vs 'none'.t-statistic\": 1,\n",
       " \"'exogenous versican (VCAN)' vs 'none'.log2foldchange\": 1,\n",
       " \"'ovarian cancer' vs 'normal' in 'epithelial cell'.p-value\": 1,\n",
       " \"'ovarian cancer' vs 'normal' in 'epithelial cell'.t-statistic\": 1,\n",
       " \"'ovarian cancer' vs 'normal' in 'epithelial cell'.log2foldchange\": 1,\n",
       " \"'ovarian cancer' vs 'normal' in 'stromal cell'.p-value\": 1,\n",
       " \"'ovarian cancer' vs 'normal' in 'stromal cell'.t-statistic\": 1,\n",
       " \"'ovarian cancer' vs 'normal' in 'stromal cell'.log2foldchange\": 1,\n",
       " \"'recombinant human MFAP5 protein' vs 'vehicle control'.p-value\": 1,\n",
       " \"'recombinant human MFAP5 protein' vs 'vehicle control'.t-statistic\": 1,\n",
       " \"'recombinant human MFAP5 protein' vs 'vehicle control'.log2foldchange\": 1,\n",
       " \"'MCF-7; ACSL4-transfected' vs 'MCF-7; control'.p-value\": 1,\n",
       " \"'MCF-7; ACSL4-transfected' vs 'MCF-7; control'.t-statistic\": 1,\n",
       " \"'MCF-7; ACSL4-transfected' vs 'MCF-7; control'.log2foldchange\": 1,\n",
       " \"'MCF-7; ACSL4-induced' vs 'MCF-7; control induced'.p-value\": 1,\n",
       " \"'MCF-7; ACSL4-induced' vs 'MCF-7; control induced'.t-statistic\": 1,\n",
       " \"'MCF-7; ACSL4-induced' vs 'MCF-7; control induced'.log2foldchange\": 1,\n",
       " \"'SKBR3; ACSL4-transfected' vs 'SKBR3; control'.p-value\": 1,\n",
       " \"'SKBR3; ACSL4-transfected' vs 'SKBR3; control'.t-statistic\": 1,\n",
       " \"'SKBR3; ACSL4-transfected' vs 'SKBR3; control'.log2foldchange\": 1,\n",
       " \"'ectopic expression of miR-34c' vs 'ectopic expression of scramble mimic'.p-value\": 1,\n",
       " \"'ectopic expression of miR-34c' vs 'ectopic expression of scramble mimic'.t-statistic\": 1,\n",
       " \"'ectopic expression of miR-34c' vs 'ectopic expression of scramble mimic'.log2foldchange\": 1,\n",
       " \"'minor tumor' vs 'normal' in 'IL28B rs8099917 TG/GG'.p-value\": 1,\n",
       " \"'minor tumor' vs 'normal' in 'IL28B rs8099917 TG/GG'.t-statistic\": 1,\n",
       " \"'minor tumor' vs 'normal' in 'IL28B rs8099917 TG/GG'.log2foldchange\": 1,\n",
       " \"'major tumor' vs 'normal 'IL28B rs8099917 TT'.p-value\": 1,\n",
       " \"'major tumor' vs 'normal 'IL28B rs8099917 TT'.t-statistic\": 1,\n",
       " \"'major tumor' vs 'normal 'IL28B rs8099917 TT'.log2foldchange\": 1,\n",
       " \"'colorectal cancer' vs 'none'.p-value\": 1,\n",
       " \"'colorectal cancer' vs 'none'.t-statistic\": 1,\n",
       " \"'colorectal cancer' vs 'none'.log2foldchange\": 1,\n",
       " \"'inflammatory bowel disease' vs 'none'.p-value\": 1,\n",
       " \"'inflammatory bowel disease' vs 'none'.t-statistic\": 1,\n",
       " \"'inflammatory bowel disease' vs 'none'.log2foldchange\": 1,\n",
       " \"'colon adenoma' vs 'none'.p-value\": 1,\n",
       " \"'colon adenoma' vs 'none'.t-statistic\": 1,\n",
       " \"'colon adenoma' vs 'none'.log2foldchange\": 1,\n",
       " \"'AS1411 aptamer' vs 'control'.p-value\": 1,\n",
       " \"'AS1411 aptamer' vs 'control'.t-statistic\": 1,\n",
       " \"'AS1411 aptamer' vs 'control'.log2foldchange\": 1,\n",
       " \"'small activating RNA; 50 nanomolar' vs 'none; '.p-value\": 1,\n",
       " \"'small activating RNA; 50 nanomolar' vs 'none; '.t-statistic\": 1,\n",
       " \"'small activating RNA; 50 nanomolar' vs 'none; '.log2foldchange\": 1,\n",
       " \"'highly invasive' vs 'poorly invasive'.p-value\": 1,\n",
       " \"'highly invasive' vs 'poorly invasive'.t-statistic\": 1,\n",
       " \"'highly invasive' vs 'poorly invasive'.log2foldchange\": 1,\n",
       " \"'doxycycline-mediated expression of dominant-negative Sox2' vs 'control' at '18 hour'.p-value\": 1,\n",
       " \"'doxycycline-mediated expression of dominant-negative Sox2' vs 'control' at '18 hour'.t-statistic\": 1,\n",
       " \"'doxycycline-mediated expression of dominant-negative Sox2' vs 'control' at '18 hour'.log2foldchange\": 1,\n",
       " \"'doxycycline-mediated expression of dominant-negative Sox2' vs 'control' at '24 hour'.p-value\": 1,\n",
       " \"'doxycycline-mediated expression of dominant-negative Sox2' vs 'control' at '24 hour'.t-statistic\": 1,\n",
       " \"'doxycycline-mediated expression of dominant-negative Sox2' vs 'control' at '24 hour'.log2foldchange\": 1,\n",
       " \"'PanIN lesion' vs 'normal' on 'Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]' on 'Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]'.p-value\": 1,\n",
       " \"'PanIN lesion' vs 'normal' on 'Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]' on 'Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]'.t-statistic\": 1,\n",
       " \"'PanIN lesion' vs 'normal' on 'Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]' on 'Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]'.log2foldchange\": 1,\n",
       " \"'pancreatic cancer' vs 'normal' on 'Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]' on 'Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]'.p-value\": 1,\n",
       " \"'pancreatic cancer' vs 'normal' on 'Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]' on 'Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]'.t-statistic\": 1,\n",
       " \"'pancreatic cancer' vs 'normal' on 'Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]' on 'Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]'.log2foldchange\": 1,\n",
       " \"'supplemented with 1:1 ratio of MSC' vs 'without MSC supplementation'.p-value\": 1,\n",
       " \"'supplemented with 1:1 ratio of MSC' vs 'without MSC supplementation'.log2foldchange\": 1,\n",
       " \"'ETS2 siRNA' vs 'control scrambled siRNA'.p-value\": 1,\n",
       " \"'ETS2 siRNA' vs 'control scrambled siRNA'.t-statistic\": 1,\n",
       " \"'ETS2 siRNA' vs 'control scrambled siRNA'.log2foldchange\": 1,\n",
       " \"'SGTA specific siRNA' vs 'non-specific siRNA' in 'vehicle'.p-value\": 1,\n",
       " \"'SGTA specific siRNA' vs 'non-specific siRNA' in 'vehicle'.t-statistic\": 1,\n",
       " \"'SGTA specific siRNA' vs 'non-specific siRNA' in 'vehicle'.log2foldchange\": 1,\n",
       " \"'lung carcinoma' vs 'normal'.p-value\": 1,\n",
       " \"'lung carcinoma' vs 'normal'.t-statistic\": 1,\n",
       " \"'lung carcinoma' vs 'normal'.log2foldchange\": 1,\n",
       " \"'non-small cell lung carcinoma' vs 'normal'.p-value\": 1,\n",
       " \"'non-small cell lung carcinoma' vs 'normal'.t-statistic\": 1,\n",
       " \"'non-small cell lung carcinoma' vs 'normal'.log2foldchange\": 1,\n",
       " \"'normal lung epithelia closest to the tumor; normal airway epithelia' vs '; normal'.p-value\": 1,\n",
       " \"'normal lung epithelia closest to the tumor; normal airway epithelia' vs '; normal'.t-statistic\": 1,\n",
       " \"'normal lung epithelia closest to the tumor; normal airway epithelia' vs '; normal'.log2foldchange\": 1,\n",
       " \"'normal lung epithelia farthest from the tumor; normal airway epithelia' vs '; normal'.p-value\": 1,\n",
       " \"'normal lung epithelia farthest from the tumor; normal airway epithelia' vs '; normal'.t-statistic\": 1,\n",
       " \"'normal lung epithelia farthest from the tumor; normal airway epithelia' vs '; normal'.log2foldchange\": 1,\n",
       " \"'normal lung epithelia the second closest to the tumor; normal airway epithelia' vs '; normal'.p-value\": 1,\n",
       " \"'normal lung epithelia the second closest to the tumor; normal airway epithelia' vs '; normal'.t-statistic\": 1,\n",
       " \"'normal lung epithelia the second closest to the tumor; normal airway epithelia' vs '; normal'.log2foldchange\": 1,\n",
       " \"'normal lung epithelia the second farthest from the tumor; normal airway epithelia' vs '; normal'.p-value\": 1,\n",
       " \"'normal lung epithelia the second farthest from the tumor; normal airway epithelia' vs '; normal'.t-statistic\": 1,\n",
       " \"'normal lung epithelia the second farthest from the tumor; normal airway epithelia' vs '; normal'.log2foldchange\": 1,\n",
       " \"'normal lung epithelia the third closest to the tumor; normal airway epithelia' vs '; normal'.p-value\": 1,\n",
       " \"'normal lung epithelia the third closest to the tumor; normal airway epithelia' vs '; normal'.t-statistic\": 1,\n",
       " \"'normal lung epithelia the third closest to the tumor; normal airway epithelia' vs '; normal'.log2foldchange\": 1,\n",
       " \"'doxycycline' vs 'none'.p-value\": 1,\n",
       " \"'doxycycline' vs 'none'.t-statistic\": 1,\n",
       " \"'doxycycline' vs 'none'.log2foldchange\": 1,\n",
       " \"'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation'.p-value\": 1,\n",
       " \"'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation'.t-statistic\": 1,\n",
       " \"'lymph node metastasis' vs 'unaffected lymph node' at 'metastatic at presentation'.log2foldchange\": 1,\n",
       " \"'lymph node metastasis' vs 'primary tumor' at 'metastatic at presentation'.p-value\": 1,\n",
       " \"'lymph node metastasis' vs 'primary tumor' at 'metastatic at presentation'.t-statistic\": 1,\n",
       " \"'lymph node metastasis' vs 'primary tumor' at 'metastatic at presentation'.log2foldchange\": 1,\n",
       " \"'metastatic at presentation; primary tumor' vs 'non-metastatic at presentation; primary tumor'.p-value\": 1,\n",
       " \"'metastatic at presentation; primary tumor' vs 'non-metastatic at presentation; primary tumor'.t-statistic\": 1,\n",
       " \"'metastatic at presentation; primary tumor' vs 'non-metastatic at presentation; primary tumor'.log2foldchange\": 1,\n",
       " \"'inflammatory breast cancer' vs 'normal'.p-value\": 1,\n",
       " \"'inflammatory breast cancer' vs 'normal'.t-statistic\": 1,\n",
       " \"'inflammatory breast cancer' vs 'normal'.log2foldchange\": 1,\n",
       " \"'non-inflammatory breast cancer' vs 'normal'.p-value\": 1,\n",
       " \"'non-inflammatory breast cancer' vs 'normal'.t-statistic\": 1,\n",
       " \"'non-inflammatory breast cancer' vs 'normal'.log2foldchange\": 1,\n",
       " \"'Capan-2; CI-1040; 2 millimolar' vs 'Capan-2; vehicle; '.p-value\": 1,\n",
       " \"'Capan-2; CI-1040; 2 millimolar' vs 'Capan-2; vehicle; '.t-statistic\": 1,\n",
       " \"'Capan-2; CI-1040; 2 millimolar' vs 'Capan-2; vehicle; '.log2foldchange\": 1,\n",
       " \"'HPAF_II; CI-1040; 2 millimolar' vs 'HPAF_II; vehicle; '.p-value\": 1,\n",
       " \"'HPAF_II; CI-1040; 2 millimolar' vs 'HPAF_II; vehicle; '.t-statistic\": 1,\n",
       " \"'HPAF_II; CI-1040; 2 millimolar' vs 'HPAF_II; vehicle; '.log2foldchange\": 1,\n",
       " \"'Hs766T; CI-1040; 2 millimolar' vs 'Hs766T; vehicle; '.p-value\": 1,\n",
       " \"'Hs766T; CI-1040; 2 millimolar' vs 'Hs766T; vehicle; '.t-statistic\": 1,\n",
       " \"'Hs766T; CI-1040; 2 millimolar' vs 'Hs766T; vehicle; '.log2foldchange\": 1,\n",
       " \"'L3.3; CI-1040; 2 millimolar' vs 'L3.3; vehicle; '.p-value\": 1,\n",
       " \"'L3.3; CI-1040; 2 millimolar' vs 'L3.3; vehicle; '.t-statistic\": 1,\n",
       " \"'L3.3; CI-1040; 2 millimolar' vs 'L3.3; vehicle; '.log2foldchange\": 1,\n",
       " \"'L3.6pl; CI-1040; 2 millimolar' vs 'L3.6pl; vehicle; '.p-value\": 1,\n",
       " \"'L3.6pl; CI-1040; 2 millimolar' vs 'L3.6pl; vehicle; '.t-statistic\": 1,\n",
       " \"'L3.6pl; CI-1040; 2 millimolar' vs 'L3.6pl; vehicle; '.log2foldchange\": 1,\n",
       " \"'L3.6sl; CI-1040; 2 millimolar' vs 'L3.6sl; vehicle; '.p-value\": 1,\n",
       " \"'L3.6sl; CI-1040; 2 millimolar' vs 'L3.6sl; vehicle; '.t-statistic\": 1,\n",
       " \"'L3.6sl; CI-1040; 2 millimolar' vs 'L3.6sl; vehicle; '.log2foldchange\": 1,\n",
       " \"'MIAPaCa-2; CI-1040; 2 millimolar' vs 'MIAPaCa-2; vehicle; '.p-value\": 1,\n",
       " \"'MIAPaCa-2; CI-1040; 2 millimolar' vs 'MIAPaCa-2; vehicle; '.t-statistic\": 1,\n",
       " \"'MIAPaCa-2; CI-1040; 2 millimolar' vs 'MIAPaCa-2; vehicle; '.log2foldchange\": 1,\n",
       " \"'PANC-1; CI-1040; 2 millimolar' vs 'PANC-1; vehicle; '.p-value\": 1,\n",
       " \"'PANC-1; CI-1040; 2 millimolar' vs 'PANC-1; vehicle; '.t-statistic\": 1,\n",
       " \"'PANC-1; CI-1040; 2 millimolar' vs 'PANC-1; vehicle; '.log2foldchange\": 1,\n",
       " \"'PL45; CI-1040; 2 millimolar' vs 'PL45; vehicle; '.p-value\": 1,\n",
       " \"'PL45; CI-1040; 2 millimolar' vs 'PL45; vehicle; '.t-statistic\": 1,\n",
       " \"'PL45; CI-1040; 2 millimolar' vs 'PL45; vehicle; '.log2foldchange\": 1,\n",
       " \"'Panc-10.05; CI-1040; 2 millimolar' vs 'Panc-10.05; vehicle; '.p-value\": 1,\n",
       " \"'Panc-10.05; CI-1040; 2 millimolar' vs 'Panc-10.05; vehicle; '.t-statistic\": 1,\n",
       " \"'Panc-10.05; CI-1040; 2 millimolar' vs 'Panc-10.05; vehicle; '.log2foldchange\": 1,\n",
       " \"'Panc-2.03; CI-1040; 2 millimolar' vs 'Panc-2.03; vehicle; '.p-value\": 1,\n",
       " \"'Panc-2.03; CI-1040; 2 millimolar' vs 'Panc-2.03; vehicle; '.t-statistic\": 1,\n",
       " \"'Panc-2.03; CI-1040; 2 millimolar' vs 'Panc-2.03; vehicle; '.log2foldchange\": 1,\n",
       " \"'Panc-2.13; CI-1040; 2 millimolar' vs 'Panc-2.13; vehicle; '.p-value\": 1,\n",
       " \"'Panc-2.13; CI-1040; 2 millimolar' vs 'Panc-2.13; vehicle; '.t-statistic\": 1,\n",
       " \"'Panc-2.13; CI-1040; 2 millimolar' vs 'Panc-2.13; vehicle; '.log2foldchange\": 1,\n",
       " \"'Panc-3.27; CI-1040; 2 millimolar' vs 'Panc-3.27; vehicle; '.p-value\": 1,\n",
       " \"'Panc-3.27; CI-1040; 2 millimolar' vs 'Panc-3.27; vehicle; '.t-statistic\": 1,\n",
       " \"'Panc-3.27; CI-1040; 2 millimolar' vs 'Panc-3.27; vehicle; '.log2foldchange\": 1,\n",
       " \"'Panc-5.04; CI-1040; 2 millimolar' vs 'Panc-5.04; vehicle; '.p-value\": 1,\n",
       " \"'Panc-5.04; CI-1040; 2 millimolar' vs 'Panc-5.04; vehicle; '.t-statistic\": 1,\n",
       " \"'Panc-5.04; CI-1040; 2 millimolar' vs 'Panc-5.04; vehicle; '.log2foldchange\": 1,\n",
       " \"'Panc-6.03; CI-1040; 2 millimolar' vs 'Panc-6.03; vehicle; '.p-value\": 1,\n",
       " \"'Panc-6.03; CI-1040; 2 millimolar' vs 'Panc-6.03; vehicle; '.t-statistic\": 1,\n",
       " \"'Panc-6.03; CI-1040; 2 millimolar' vs 'Panc-6.03; vehicle; '.log2foldchange\": 1,\n",
       " \"'Panc-8.13; CI-1040; 2 millimolar' vs 'Panc-8.13; vehicle; '.p-value\": 1,\n",
       " \"'Panc-8.13; CI-1040; 2 millimolar' vs 'Panc-8.13; vehicle; '.t-statistic\": 1,\n",
       " \"'Panc-8.13; CI-1040; 2 millimolar' vs 'Panc-8.13; vehicle; '.log2foldchange\": 1,\n",
       " \"'SU86.86; CI-1040; 2 millimolar' vs 'SU86.86; vehicle; '.p-value\": 1,\n",
       " \"'SU86.86; CI-1040; 2 millimolar' vs 'SU86.86; vehicle; '.t-statistic\": 1,\n",
       " \"'SU86.86; CI-1040; 2 millimolar' vs 'SU86.86; vehicle; '.log2foldchange\": 1,\n",
       " \"'SW1990; CI-1040; 2 millimolar' vs 'SW1990; vehicle; '.p-value\": 1,\n",
       " \"'SW1990; CI-1040; 2 millimolar' vs 'SW1990; vehicle; '.t-statistic\": 1,\n",
       " \"'SW1990; CI-1040; 2 millimolar' vs 'SW1990; vehicle; '.log2foldchange\": 1,\n",
       " \"'BxPC-3; CI-1040; 2 millimolar' vs 'BxPC-3; vehicle; '.p-value\": 1,\n",
       " \"'BxPC-3; CI-1040; 2 millimolar' vs 'BxPC-3; vehicle; '.t-statistic\": 1,\n",
       " \"'BxPC-3; CI-1040; 2 millimolar' vs 'BxPC-3; vehicle; '.log2foldchange\": 1,\n",
       " \"'CFPAC-1; CI-1040; 2 millimolar' vs 'CFPAC-1; vehicle; '.p-value\": 1,\n",
       " \"'CFPAC-1; CI-1040; 2 millimolar' vs 'CFPAC-1; vehicle; '.t-statistic\": 1,\n",
       " \"'CFPAC-1; CI-1040; 2 millimolar' vs 'CFPAC-1; vehicle; '.log2foldchange\": 1,\n",
       " \"'COLO357; CI-1040; 2 millimolar' vs 'COLO357; vehicle; '.p-value\": 1,\n",
       " \"'COLO357; CI-1040; 2 millimolar' vs 'COLO357; vehicle; '.t-statistic\": 1,\n",
       " \"'COLO357; CI-1040; 2 millimolar' vs 'COLO357; vehicle; '.log2foldchange\": 1,\n",
       " \"'Nutlin-3; 10 micromolar' vs 'DMSO; 0.1 percent'.p-value\": 1,\n",
       " \"'Nutlin-3; 10 micromolar' vs 'DMSO; 0.1 percent'.t-statistic\": 1,\n",
       " \"'Nutlin-3; 10 micromolar' vs 'DMSO; 0.1 percent'.log2foldchange\": 1,\n",
       " \"'doxorubicin; 0.6 microgram per milliliter' vs 'none'.p-value\": 1,\n",
       " \"'doxorubicin; 0.6 microgram per milliliter' vs 'none'.t-statistic\": 1,\n",
       " \"'doxorubicin; 0.6 microgram per milliliter' vs 'none'.log2foldchange\": 1,\n",
       " \"'serum from breast cancer patients exposed to aerobic training' vs 'serum from sedentary control breast cancer patient'.p-value\": 1,\n",
       " \"'serum from breast cancer patients exposed to aerobic training' vs 'serum from sedentary control breast cancer patient'.t-statistic\": 1,\n",
       " \"'serum from breast cancer patients exposed to aerobic training' vs 'serum from sedentary control breast cancer patient'.log2foldchange\": 1,\n",
       " \"'anti-VEGF antibody' vs 'control IgG'.p-value\": 1,\n",
       " \"'anti-VEGF antibody' vs 'control IgG'.t-statistic\": 1,\n",
       " \"'anti-VEGF antibody' vs 'control IgG'.log2foldchange\": 1,\n",
       " \"'OVOL1 overexpression; mesenchymal' vs 'control; epithelial transformed to Mesenchymal'.p-value\": 1,\n",
       " \"'OVOL1 overexpression; mesenchymal' vs 'control; epithelial transformed to Mesenchymal'.log2foldchange\": 1,\n",
       " \"'after androgen ablation therapy' vs 'before androgen ablation therapy'.p-value\": 1,\n",
       " \"'after androgen ablation therapy' vs 'before androgen ablation therapy'.log2foldchange\": 1,\n",
       " \"'MOLT-4; acute lymphoblastic leukemia; P01' vs 'MOLT-4; acute lymphoblastic leukemia; P0'.p-value\": 1,\n",
       " \"'MOLT-4; acute lymphoblastic leukemia; P01' vs 'MOLT-4; acute lymphoblastic leukemia; P0'.t-statistic\": 1,\n",
       " \"'MOLT-4; acute lymphoblastic leukemia; P01' vs 'MOLT-4; acute lymphoblastic leukemia; P0'.log2foldchange\": 1,\n",
       " \"'MOLT-4; acute lymphoblastic leukemia; P04' vs 'MOLT-4; acute lymphoblastic leukemia; P0'.p-value\": 1,\n",
       " \"'MOLT-4; acute lymphoblastic leukemia; P04' vs 'MOLT-4; acute lymphoblastic leukemia; P0'.t-statistic\": 1,\n",
       " \"'MOLT-4; acute lymphoblastic leukemia; P04' vs 'MOLT-4; acute lymphoblastic leukemia; P0'.log2foldchange\": 1,\n",
       " \"'MOLT-4; acute lymphoblastic leukemia; P10' vs 'MOLT-4; acute lymphoblastic leukemia; P0'.p-value\": 1,\n",
       " \"'MOLT-4; acute lymphoblastic leukemia; P10' vs 'MOLT-4; acute lymphoblastic leukemia; P0'.t-statistic\": 1,\n",
       " \"'MOLT-4; acute lymphoblastic leukemia; P10' vs 'MOLT-4; acute lymphoblastic leukemia; P0'.log2foldchange\": 1,\n",
       " \"'NCI-H226; squamous cell lung carcinoma; P04' vs 'NCI-H226; squamous cell lung carcinoma; P0'.p-value\": 1,\n",
       " \"'NCI-H226; squamous cell lung carcinoma; P04' vs 'NCI-H226; squamous cell lung carcinoma; P0'.t-statistic\": 1,\n",
       " \"'NCI-H226; squamous cell lung carcinoma; P04' vs 'NCI-H226; squamous cell lung carcinoma; P0'.log2foldchange\": 1,\n",
       " \"'NCI-H226; squamous cell lung carcinoma; P10' vs 'NCI-H226; squamous cell lung carcinoma; P0'.p-value\": 1,\n",
       " \"'NCI-H226; squamous cell lung carcinoma; P10' vs 'NCI-H226; squamous cell lung carcinoma; P0'.t-statistic\": 1,\n",
       " \"'NCI-H226; squamous cell lung carcinoma; P10' vs 'NCI-H226; squamous cell lung carcinoma; P0'.log2foldchange\": 1,\n",
       " \"'A549; adenocarcinoma of lung; P01' vs 'A549; adenocarcinoma of lung; P0'.p-value\": 1,\n",
       " \"'A549; adenocarcinoma of lung; P01' vs 'A549; adenocarcinoma of lung; P0'.t-statistic\": 1,\n",
       " \"'A549; adenocarcinoma of lung; P01' vs 'A549; adenocarcinoma of lung; P0'.log2foldchange\": 1,\n",
       " \"'A549; adenocarcinoma of lung; P04' vs 'A549; adenocarcinoma of lung; P0'.p-value\": 1,\n",
       " \"'A549; adenocarcinoma of lung; P04' vs 'A549; adenocarcinoma of lung; P0'.t-statistic\": 1,\n",
       " \"'A549; adenocarcinoma of lung; P04' vs 'A549; adenocarcinoma of lung; P0'.log2foldchange\": 1,\n",
       " \"'A549; adenocarcinoma of lung; P10' vs 'A549; adenocarcinoma of lung; P0'.p-value\": 1,\n",
       " \"'A549; adenocarcinoma of lung; P10' vs 'A549; adenocarcinoma of lung; P0'.t-statistic\": 1,\n",
       " \"'A549; adenocarcinoma of lung; P10' vs 'A549; adenocarcinoma of lung; P0'.log2foldchange\": 1,\n",
       " \"'NCI-H460; large cell lung carcinoma; P01' vs 'NCI-H460; large cell lung carcinoma; P0'.p-value\": 1,\n",
       " \"'NCI-H460; large cell lung carcinoma; P01' vs 'NCI-H460; large cell lung carcinoma; P0'.t-statistic\": 1,\n",
       " \"'NCI-H460; large cell lung carcinoma; P01' vs 'NCI-H460; large cell lung carcinoma; P0'.log2foldchange\": 1,\n",
       " \"'NCI-H460; large cell lung carcinoma; P04' vs 'NCI-H460; large cell lung carcinoma; P0'.p-value\": 1,\n",
       " \"'NCI-H460; large cell lung carcinoma; P04' vs 'NCI-H460; large cell lung carcinoma; P0'.t-statistic\": 1,\n",
       " \"'NCI-H460; large cell lung carcinoma; P04' vs 'NCI-H460; large cell lung carcinoma; P0'.log2foldchange\": 1,\n",
       " \"'NCI-H460; large cell lung carcinoma; P10' vs 'NCI-H460; large cell lung carcinoma; P0'.p-value\": 1,\n",
       " \"'NCI-H460; large cell lung carcinoma; P10' vs 'NCI-H460; large cell lung carcinoma; P0'.t-statistic\": 1,\n",
       " \"'NCI-H460; large cell lung carcinoma; P10' vs 'NCI-H460; large cell lung carcinoma; P0'.log2foldchange\": 1,\n",
       " \"'PC-3/M; adenocarcinoma prostate PC-3 subline isolated from liver metastasis in mice; P01' vs 'PC-3/M; adenocarcinoma prostate PC-3 subline isolated from liver metastasis in mice; P0'.p-value\": 1,\n",
       " \"'PC-3/M; adenocarcinoma prostate PC-3 subline isolated from liver metastasis in mice; P01' vs 'PC-3/M; adenocarcinoma prostate PC-3 subline isolated from liver metastasis in mice; P0'.t-statistic\": 1,\n",
       " \"'PC-3/M; adenocarcinoma prostate PC-3 subline isolated from liver metastasis in mice; P01' vs 'PC-3/M; adenocarcinoma prostate PC-3 subline isolated from liver metastasis in mice; P0'.log2foldchange\": 1,\n",
       " \"'PC-3/M; adenocarcinoma prostate PC-3 subline isolated from liver metastasis in mice; P04' vs 'PC-3/M; adenocarcinoma prostate PC-3 subline isolated from liver metastasis in mice; P0'.p-value\": 1,\n",
       " \"'PC-3/M; adenocarcinoma prostate PC-3 subline isolated from liver metastasis in mice; P04' vs 'PC-3/M; adenocarcinoma prostate PC-3 subline isolated from liver metastasis in mice; P0'.t-statistic\": 1,\n",
       " \"'PC-3/M; adenocarcinoma prostate PC-3 subline isolated from liver metastasis in mice; P04' vs 'PC-3/M; adenocarcinoma prostate PC-3 subline isolated from liver metastasis in mice; P0'.log2foldchange\": 1,\n",
       " \"'PC-3/M; adenocarcinoma prostate PC-3 subline isolated from liver metastasis in mice; P10' vs 'PC-3/M; adenocarcinoma prostate PC-3 subline isolated from liver metastasis in mice; P0'.p-value\": 1,\n",
       " \"'PC-3/M; adenocarcinoma prostate PC-3 subline isolated from liver metastasis in mice; P10' vs 'PC-3/M; adenocarcinoma prostate PC-3 subline isolated from liver metastasis in mice; P0'.t-statistic\": 1,\n",
       " \"'PC-3/M; adenocarcinoma prostate PC-3 subline isolated from liver metastasis in mice; P10' vs 'PC-3/M; adenocarcinoma prostate PC-3 subline isolated from liver metastasis in mice; P0'.log2foldchange\": 1,\n",
       " \"'RXF 393; poorly differentiated hypernephroma; P01' vs 'RXF 393; poorly differentiated hypernephroma; P0'.p-value\": 1,\n",
       " \"'RXF 393; poorly differentiated hypernephroma; P01' vs 'RXF 393; poorly differentiated hypernephroma; P0'.t-statistic\": 1,\n",
       " \"'RXF 393; poorly differentiated hypernephroma; P01' vs 'RXF 393; poorly differentiated hypernephroma; P0'.log2foldchange\": 1,\n",
       " \"'RXF 393; poorly differentiated hypernephroma; P04' vs 'RXF 393; poorly differentiated hypernephroma; P0'.p-value\": 1,\n",
       " \"'RXF 393; poorly differentiated hypernephroma; P04' vs 'RXF 393; poorly differentiated hypernephroma; P0'.t-statistic\": 1,\n",
       " \"'RXF 393; poorly differentiated hypernephroma; P04' vs 'RXF 393; poorly differentiated hypernephroma; P0'.log2foldchange\": 1,\n",
       " \"'RXF 393; poorly differentiated hypernephroma; P10' vs 'RXF 393; poorly differentiated hypernephroma; P0'.p-value\": 1,\n",
       " \"'RXF 393; poorly differentiated hypernephroma; P10' vs 'RXF 393; poorly differentiated hypernephroma; P0'.t-statistic\": 1,\n",
       " \"'RXF 393; poorly differentiated hypernephroma; P10' vs 'RXF 393; poorly differentiated hypernephroma; P0'.log2foldchange\": 1,\n",
       " \"'SR; poorly differentiated B cell origin leukemia; P01' vs 'SR; poorly differentiated B cell origin leukemia; P0'.p-value\": 1,\n",
       " \"'SR; poorly differentiated B cell origin leukemia; P01' vs 'SR; poorly differentiated B cell origin leukemia; P0'.t-statistic\": 1,\n",
       " \"'SR; poorly differentiated B cell origin leukemia; P01' vs 'SR; poorly differentiated B cell origin leukemia; P0'.log2foldchange\": 1,\n",
       " \"'SR; poorly differentiated B cell origin leukemia; P04' vs 'SR; poorly differentiated B cell origin leukemia; P0'.p-value\": 1,\n",
       " \"'SR; poorly differentiated B cell origin leukemia; P04' vs 'SR; poorly differentiated B cell origin leukemia; P0'.t-statistic\": 1,\n",
       " \"'SR; poorly differentiated B cell origin leukemia; P04' vs 'SR; poorly differentiated B cell origin leukemia; P0'.log2foldchange\": 1,\n",
       " \"'SR; poorly differentiated B cell origin leukemia; P10' vs 'SR; poorly differentiated B cell origin leukemia; P0'.p-value\": 1,\n",
       " \"'SR; poorly differentiated B cell origin leukemia; P10' vs 'SR; poorly differentiated B cell origin leukemia; P0'.t-statistic\": 1,\n",
       " \"'SR; poorly differentiated B cell origin leukemia; P10' vs 'SR; poorly differentiated B cell origin leukemia; P0'.log2foldchange\": 1,\n",
       " \"'SW-620; adenocarcinoma of colon; P01' vs 'SW-620; adenocarcinoma of colon; P0'.p-value\": 1,\n",
       " \"'SW-620; adenocarcinoma of colon; P01' vs 'SW-620; adenocarcinoma of colon; P0'.t-statistic\": 1,\n",
       " \"'SW-620; adenocarcinoma of colon; P01' vs 'SW-620; adenocarcinoma of colon; P0'.log2foldchange\": 1,\n",
       " \"'SW-620; adenocarcinoma of colon; P04' vs 'SW-620; adenocarcinoma of colon; P0'.p-value\": 1,\n",
       " \"'SW-620; adenocarcinoma of colon; P04' vs 'SW-620; adenocarcinoma of colon; P0'.t-statistic\": 1,\n",
       " \"'SW-620; adenocarcinoma of colon; P04' vs 'SW-620; adenocarcinoma of colon; P0'.log2foldchange\": 1,\n",
       " \"'SW-620; adenocarcinoma of colon; P10' vs 'SW-620; adenocarcinoma of colon; P0'.p-value\": 1,\n",
       " \"'SW-620; adenocarcinoma of colon; P10' vs 'SW-620; adenocarcinoma of colon; P0'.t-statistic\": 1,\n",
       " \"'SW-620; adenocarcinoma of colon; P10' vs 'SW-620; adenocarcinoma of colon; P0'.log2foldchange\": 1,\n",
       " \"'UACC-62; melanoma; P01' vs 'UACC-62; melanoma; P0'.p-value\": 1,\n",
       " \"'UACC-62; melanoma; P01' vs 'UACC-62; melanoma; P0'.t-statistic\": 1,\n",
       " \"'UACC-62; melanoma; P01' vs 'UACC-62; melanoma; P0'.log2foldchange\": 1,\n",
       " \"'UACC-62; melanoma; P04' vs 'UACC-62; melanoma; P0'.p-value\": 1,\n",
       " \"'UACC-62; melanoma; P04' vs 'UACC-62; melanoma; P0'.t-statistic\": 1,\n",
       " \"'UACC-62; melanoma; P04' vs 'UACC-62; melanoma; P0'.log2foldchange\": 1,\n",
       " \"'UACC-62; melanoma; P10' vs 'UACC-62; melanoma; P0'.p-value\": 1,\n",
       " \"'UACC-62; melanoma; P10' vs 'UACC-62; melanoma; P0'.t-statistic\": 1,\n",
       " \"'UACC-62; melanoma; P10' vs 'UACC-62; melanoma; P0'.log2foldchange\": 1,\n",
       " \"'AsPC-1; pancreatic adenocarcinoma; P01' vs 'AsPC-1; pancreatic adenocarcinoma; P0'.p-value\": 1,\n",
       " \"'AsPC-1; pancreatic adenocarcinoma; P01' vs 'AsPC-1; pancreatic adenocarcinoma; P0'.t-statistic\": 1,\n",
       " \"'AsPC-1; pancreatic adenocarcinoma; P01' vs 'AsPC-1; pancreatic adenocarcinoma; P0'.log2foldchange\": 1,\n",
       " \"'AsPC-1; pancreatic adenocarcinoma; P04' vs 'AsPC-1; pancreatic adenocarcinoma; P0'.p-value\": 1,\n",
       " \"'AsPC-1; pancreatic adenocarcinoma; P04' vs 'AsPC-1; pancreatic adenocarcinoma; P0'.t-statistic\": 1,\n",
       " \"'AsPC-1; pancreatic adenocarcinoma; P04' vs 'AsPC-1; pancreatic adenocarcinoma; P0'.log2foldchange\": 1,\n",
       " \"'AsPC-1; pancreatic adenocarcinoma; P10' vs 'AsPC-1; pancreatic adenocarcinoma; P0'.p-value\": 1,\n",
       " \"'AsPC-1; pancreatic adenocarcinoma; P10' vs 'AsPC-1; pancreatic adenocarcinoma; P0'.t-statistic\": 1,\n",
       " \"'AsPC-1; pancreatic adenocarcinoma; P10' vs 'AsPC-1; pancreatic adenocarcinoma; P0'.log2foldchange\": 1,\n",
       " \"'786-0; renal adenocarcinoma; P01' vs '786-0; renal adenocarcinoma; P0'.p-value\": 1,\n",
       " \"'786-0; renal adenocarcinoma; P01' vs '786-0; renal adenocarcinoma; P0'.t-statistic\": 1,\n",
       " \"'786-0; renal adenocarcinoma; P01' vs '786-0; renal adenocarcinoma; P0'.log2foldchange\": 1,\n",
       " \"'786-0; renal adenocarcinoma; P04' vs '786-0; renal adenocarcinoma; P0'.p-value\": 1,\n",
       " \"'786-0; renal adenocarcinoma; P04' vs '786-0; renal adenocarcinoma; P0'.t-statistic\": 1,\n",
       " \"'786-0; renal adenocarcinoma; P04' vs '786-0; renal adenocarcinoma; P0'.log2foldchange\": 1,\n",
       " \"'786-0; renal adenocarcinoma; P10' vs '786-0; renal adenocarcinoma; P0'.p-value\": 1,\n",
       " \"'786-0; renal adenocarcinoma; P10' vs '786-0; renal adenocarcinoma; P0'.t-statistic\": 1,\n",
       " \"'786-0; renal adenocarcinoma; P10' vs '786-0; renal adenocarcinoma; P0'.log2foldchange\": 1,\n",
       " \"'CCRF-CEM; acute lymphoblastic (T-ALL) leukemia; P01' vs 'CCRF-CEM; acute lymphoblastic (T-ALL) leukemia; P0'.p-value\": 1,\n",
       " \"'CCRF-CEM; acute lymphoblastic (T-ALL) leukemia; P01' vs 'CCRF-CEM; acute lymphoblastic (T-ALL) leukemia; P0'.t-statistic\": 1,\n",
       " \"'CCRF-CEM; acute lymphoblastic (T-ALL) leukemia; P01' vs 'CCRF-CEM; acute lymphoblastic (T-ALL) leukemia; P0'.log2foldchange\": 1,\n",
       " \"'CCRF-CEM; acute lymphoblastic (T-ALL) leukemia; P04' vs 'CCRF-CEM; acute lymphoblastic (T-ALL) leukemia; P0'.p-value\": 1,\n",
       " \"'CCRF-CEM; acute lymphoblastic (T-ALL) leukemia; P04' vs 'CCRF-CEM; acute lymphoblastic (T-ALL) leukemia; P0'.t-statistic\": 1,\n",
       " \"'CCRF-CEM; acute lymphoblastic (T-ALL) leukemia; P04' vs 'CCRF-CEM; acute lymphoblastic (T-ALL) leukemia; P0'.log2foldchange\": 1,\n",
       " \"'CCRF-CEM; acute lymphoblastic (T-ALL) leukemia; P10' vs 'CCRF-CEM; acute lymphoblastic (T-ALL) leukemia; P0'.p-value\": 1,\n",
       " \"'CCRF-CEM; acute lymphoblastic (T-ALL) leukemia; P10' vs 'CCRF-CEM; acute lymphoblastic (T-ALL) leukemia; P0'.t-statistic\": 1,\n",
       " \"'CCRF-CEM; acute lymphoblastic (T-ALL) leukemia; P10' vs 'CCRF-CEM; acute lymphoblastic (T-ALL) leukemia; P0'.log2foldchange\": 1,\n",
       " \"'COLO 205; adenocarcinoma of colon; P01' vs 'COLO 205; adenocarcinoma of colon; P0'.p-value\": 1,\n",
       " \"'COLO 205; adenocarcinoma of colon; P01' vs 'COLO 205; adenocarcinoma of colon; P0'.t-statistic\": 1,\n",
       " \"'COLO 205; adenocarcinoma of colon; P01' vs 'COLO 205; adenocarcinoma of colon; P0'.log2foldchange\": 1,\n",
       " \"'COLO 205; adenocarcinoma of colon; P04' vs 'COLO 205; adenocarcinoma of colon; P0'.p-value\": 1,\n",
       " \"'COLO 205; adenocarcinoma of colon; P04' vs 'COLO 205; adenocarcinoma of colon; P0'.t-statistic\": 1,\n",
       " \"'COLO 205; adenocarcinoma of colon; P04' vs 'COLO 205; adenocarcinoma of colon; P0'.log2foldchange\": 1,\n",
       " \"'COLO 205; adenocarcinoma of colon; P10' vs 'COLO 205; adenocarcinoma of colon; P0'.p-value\": 1,\n",
       " \"'COLO 205; adenocarcinoma of colon; P10' vs 'COLO 205; adenocarcinoma of colon; P0'.t-statistic\": 1,\n",
       " \"'COLO 205; adenocarcinoma of colon; P10' vs 'COLO 205; adenocarcinoma of colon; P0'.log2foldchange\": 1,\n",
       " \"'HCC-2998; colon carcinoma; P01' vs 'HCC-2998; colon carcinoma; P0'.p-value\": 1,\n",
       " \"'HCC-2998; colon carcinoma; P01' vs 'HCC-2998; colon carcinoma; P0'.t-statistic\": 1,\n",
       " \"'HCC-2998; colon carcinoma; P01' vs 'HCC-2998; colon carcinoma; P0'.log2foldchange\": 1,\n",
       " \"'HCC-2998; colon carcinoma; P04' vs 'HCC-2998; colon carcinoma; P0'.p-value\": 1,\n",
       " \"'HCC-2998; colon carcinoma; P04' vs 'HCC-2998; colon carcinoma; P0'.t-statistic\": 1,\n",
       " \"'HCC-2998; colon carcinoma; P04' vs 'HCC-2998; colon carcinoma; P0'.log2foldchange\": 1,\n",
       " \"'HCC-2998; colon carcinoma; P10' vs 'HCC-2998; colon carcinoma; P0'.p-value\": 1,\n",
       " \"'HCC-2998; colon carcinoma; P10' vs 'HCC-2998; colon carcinoma; P0'.t-statistic\": 1,\n",
       " \"'HCC-2998; colon carcinoma; P10' vs 'HCC-2998; colon carcinoma; P0'.log2foldchange\": 1,\n",
       " \"'HCT-116; colon carcinoma; P01' vs 'HCT-116; colon carcinoma; P0'.p-value\": 1,\n",
       " \"'HCT-116; colon carcinoma; P01' vs 'HCT-116; colon carcinoma; P0'.t-statistic\": 1,\n",
       " \"'HCT-116; colon carcinoma; P01' vs 'HCT-116; colon carcinoma; P0'.log2foldchange\": 1,\n",
       " \"'HCT-116; colon carcinoma; P04' vs 'HCT-116; colon carcinoma; P0'.p-value\": 1,\n",
       " \"'HCT-116; colon carcinoma; P04' vs 'HCT-116; colon carcinoma; P0'.t-statistic\": 1,\n",
       " \"'HCT-116; colon carcinoma; P04' vs 'HCT-116; colon carcinoma; P0'.log2foldchange\": 1,\n",
       " \"'HCT-116; colon carcinoma; P10' vs 'HCT-116; colon carcinoma; P0'.p-value\": 1,\n",
       " \"'HCT-116; colon carcinoma; P10' vs 'HCT-116; colon carcinoma; P0'.t-statistic\": 1,\n",
       " \"'HCT-116; colon carcinoma; P10' vs 'HCT-116; colon carcinoma; P0'.log2foldchange\": 1,\n",
       " \"'HCT-15; adenocarcinoma of colon; P01' vs 'HCT-15; adenocarcinoma of colon; P0'.p-value\": 1,\n",
       " \"'HCT-15; adenocarcinoma of colon; P01' vs 'HCT-15; adenocarcinoma of colon; P0'.t-statistic\": 1,\n",
       " \"'HCT-15; adenocarcinoma of colon; P01' vs 'HCT-15; adenocarcinoma of colon; P0'.log2foldchange\": 1,\n",
       " \"'HCT-15; adenocarcinoma of colon; P04' vs 'HCT-15; adenocarcinoma of colon; P0'.p-value\": 1,\n",
       " \"'HCT-15; adenocarcinoma of colon; P04' vs 'HCT-15; adenocarcinoma of colon; P0'.t-statistic\": 1,\n",
       " \"'HCT-15; adenocarcinoma of colon; P04' vs 'HCT-15; adenocarcinoma of colon; P0'.log2foldchange\": 1,\n",
       " \"'HCT-15; adenocarcinoma of colon; P10' vs 'HCT-15; adenocarcinoma of colon; P0'.p-value\": 1,\n",
       " \"'HCT-15; adenocarcinoma of colon; P10' vs 'HCT-15; adenocarcinoma of colon; P0'.t-statistic\": 1,\n",
       " \"'HCT-15; adenocarcinoma of colon; P10' vs 'HCT-15; adenocarcinoma of colon; P0'.log2foldchange\": 1,\n",
       " \"'HL-60(TB); promyelocytic leukemia; P01' vs 'HL-60(TB); promyelocytic leukemia; P0'.p-value\": 1,\n",
       " \"'HL-60(TB); promyelocytic leukemia; P01' vs 'HL-60(TB); promyelocytic leukemia; P0'.t-statistic\": 1,\n",
       " \"'HL-60(TB); promyelocytic leukemia; P01' vs 'HL-60(TB); promyelocytic leukemia; P0'.log2foldchange\": 1,\n",
       " \"'HL-60(TB); promyelocytic leukemia; P04' vs 'HL-60(TB); promyelocytic leukemia; P0'.p-value\": 1,\n",
       " \"'HL-60(TB); promyelocytic leukemia; P04' vs 'HL-60(TB); promyelocytic leukemia; P0'.t-statistic\": 1,\n",
       " \"'HL-60(TB); promyelocytic leukemia; P04' vs 'HL-60(TB); promyelocytic leukemia; P0'.log2foldchange\": 1,\n",
       " \"'HL-60(TB); promyelocytic leukemia; P10' vs 'HL-60(TB); promyelocytic leukemia; P0'.p-value\": 1,\n",
       " \"'HL-60(TB); promyelocytic leukemia; P10' vs 'HL-60(TB); promyelocytic leukemia; P0'.t-statistic\": 1,\n",
       " \"'HL-60(TB); promyelocytic leukemia; P10' vs 'HL-60(TB); promyelocytic leukemia; P0'.log2foldchange\": 1,\n",
       " \"'HOP-62; adenocarcinoma of lung; P01' vs 'HOP-62; adenocarcinoma of lung; P0'.p-value\": 1,\n",
       " \"'HOP-62; adenocarcinoma of lung; P01' vs 'HOP-62; adenocarcinoma of lung; P0'.t-statistic\": 1,\n",
       " \"'HOP-62; adenocarcinoma of lung; P01' vs 'HOP-62; adenocarcinoma of lung; P0'.log2foldchange\": 1,\n",
       " \"'HOP-62; adenocarcinoma of lung; P04' vs 'HOP-62; adenocarcinoma of lung; P0'.p-value\": 1,\n",
       " \"'HOP-62; adenocarcinoma of lung; P04' vs 'HOP-62; adenocarcinoma of lung; P0'.t-statistic\": 1,\n",
       " \"'HOP-62; adenocarcinoma of lung; P04' vs 'HOP-62; adenocarcinoma of lung; P0'.log2foldchange\": 1,\n",
       " \"'HOP-62; adenocarcinoma of lung; P10' vs 'HOP-62; adenocarcinoma of lung; P0'.p-value\": 1,\n",
       " \"'HOP-62; adenocarcinoma of lung; P10' vs 'HOP-62; adenocarcinoma of lung; P0'.t-statistic\": 1,\n",
       " \"'HOP-62; adenocarcinoma of lung; P10' vs 'HOP-62; adenocarcinoma of lung; P0'.log2foldchange\": 1,\n",
       " \"'HOP-92; large cell undifferentiated lung; P01' vs 'HOP-92; large cell undifferentiated lung; P0'.p-value\": 1,\n",
       " \"'HOP-92; large cell undifferentiated lung; P01' vs 'HOP-92; large cell undifferentiated lung; P0'.t-statistic\": 1,\n",
       " \"'HOP-92; large cell undifferentiated lung; P01' vs 'HOP-92; large cell undifferentiated lung; P0'.log2foldchange\": 1,\n",
       " \"'HOP-92; large cell undifferentiated lung; P04' vs 'HOP-92; large cell undifferentiated lung; P0'.p-value\": 1,\n",
       " \"'HOP-92; large cell undifferentiated lung; P04' vs 'HOP-92; large cell undifferentiated lung; P0'.t-statistic\": 1,\n",
       " \"'HOP-92; large cell undifferentiated lung; P04' vs 'HOP-92; large cell undifferentiated lung; P0'.log2foldchange\": 1,\n",
       " \"'HOP-92; large cell undifferentiated lung; P10' vs 'HOP-92; large cell undifferentiated lung; P0'.p-value\": 1,\n",
       " \"'HOP-92; large cell undifferentiated lung; P10' vs 'HOP-92; large cell undifferentiated lung; P0'.t-statistic\": 1,\n",
       " \"'HOP-92; large cell undifferentiated lung; P10' vs 'HOP-92; large cell undifferentiated lung; P0'.log2foldchange\": 1,\n",
       " \"'HT-29; adenocarcinoma of colon; P01' vs 'HT-29; adenocarcinoma of colon; P0'.p-value\": 1,\n",
       " \"'HT-29; adenocarcinoma of colon; P01' vs 'HT-29; adenocarcinoma of colon; P0'.t-statistic\": 1,\n",
       " \"'HT-29; adenocarcinoma of colon; P01' vs 'HT-29; adenocarcinoma of colon; P0'.log2foldchange\": 1,\n",
       " \"'HT-29; adenocarcinoma of colon; P04' vs 'HT-29; adenocarcinoma of colon; P0'.p-value\": 1,\n",
       " \"'HT-29; adenocarcinoma of colon; P04' vs 'HT-29; adenocarcinoma of colon; P0'.t-statistic\": 1,\n",
       " \"'HT-29; adenocarcinoma of colon; P04' vs 'HT-29; adenocarcinoma of colon; P0'.log2foldchange\": 1,\n",
       " \"'HT-29; adenocarcinoma of colon; P10' vs 'HT-29; adenocarcinoma of colon; P0'.p-value\": 1,\n",
       " \"'HT-29; adenocarcinoma of colon; P10' vs 'HT-29; adenocarcinoma of colon; P0'.t-statistic\": 1,\n",
       " \"'HT-29; adenocarcinoma of colon; P10' vs 'HT-29; adenocarcinoma of colon; P0'.log2foldchange\": 1,\n",
       " \"'K-562; chronic myelogenous (blast crisis) leukemia; P01' vs 'K-562; chronic myelogenous (blast crisis) leukemia; P0'.p-value\": 1,\n",
       " \"'K-562; chronic myelogenous (blast crisis) leukemia; P01' vs 'K-562; chronic myelogenous (blast crisis) leukemia; P0'.t-statistic\": 1,\n",
       " \"'K-562; chronic myelogenous (blast crisis) leukemia; P01' vs 'K-562; chronic myelogenous (blast crisis) leukemia; P0'.log2foldchange\": 1,\n",
       " \"'K-562; chronic myelogenous (blast crisis) leukemia; P04' vs 'K-562; chronic myelogenous (blast crisis) leukemia; P0'.p-value\": 1,\n",
       " \"'K-562; chronic myelogenous (blast crisis) leukemia; P04' vs 'K-562; chronic myelogenous (blast crisis) leukemia; P0'.t-statistic\": 1,\n",
       " \"'K-562; chronic myelogenous (blast crisis) leukemia; P04' vs 'K-562; chronic myelogenous (blast crisis) leukemia; P0'.log2foldchange\": 1,\n",
       " \"'K-562; chronic myelogenous (blast crisis) leukemia; P10' vs 'K-562; chronic myelogenous (blast crisis) leukemia; P0'.p-value\": 1,\n",
       " \"'K-562; chronic myelogenous (blast crisis) leukemia; P10' vs 'K-562; chronic myelogenous (blast crisis) leukemia; P0'.t-statistic\": 1,\n",
       " \"'K-562; chronic myelogenous (blast crisis) leukemia; P10' vs 'K-562; chronic myelogenous (blast crisis) leukemia; P0'.log2foldchange\": 1,\n",
       " \"'KM12; adenocarcinoma of colon; P01' vs 'KM12; adenocarcinoma of colon; P0'.p-value\": 1,\n",
       " \"'KM12; adenocarcinoma of colon; P01' vs 'KM12; adenocarcinoma of colon; P0'.t-statistic\": 1,\n",
       " \"'KM12; adenocarcinoma of colon; P01' vs 'KM12; adenocarcinoma of colon; P0'.log2foldchange\": 1,\n",
       " \"'KM12; adenocarcinoma of colon; P04' vs 'KM12; adenocarcinoma of colon; P0'.p-value\": 1,\n",
       " \"'KM12; adenocarcinoma of colon; P04' vs 'KM12; adenocarcinoma of colon; P0'.t-statistic\": 1,\n",
       " \"'KM12; adenocarcinoma of colon; P04' vs 'KM12; adenocarcinoma of colon; P0'.log2foldchange\": 1,\n",
       " \"'KM12; adenocarcinoma of colon; P10' vs 'KM12; adenocarcinoma of colon; P0'.p-value\": 1,\n",
       " \"'KM12; adenocarcinoma of colon; P10' vs 'KM12; adenocarcinoma of colon; P0'.t-statistic\": 1,\n",
       " \"'KM12; adenocarcinoma of colon; P10' vs 'KM12; adenocarcinoma of colon; P0'.log2foldchange\": 1,\n",
       " \"'DMSO; prostate carcinoma' at '24 hour' vs 'DMSO; normal' at '24 hour'.p-value\": 1,\n",
       " \"'DMSO; prostate carcinoma' at '24 hour' vs 'DMSO; normal' at '24 hour'.log2foldchange\": 1,\n",
       " \"'sulforaphane; normal' at '24 hour' vs 'DMSO; normal' at '24 hour'.p-value\": 1,\n",
       " \"'sulforaphane; normal' at '24 hour' vs 'DMSO; normal' at '24 hour'.log2foldchange\": 1,\n",
       " \"'DMSO; prostate carcinoma' at '6 hour' vs 'DMSO; normal' at '6 hour'.p-value\": 1,\n",
       " \"'DMSO; prostate carcinoma' at '6 hour' vs 'DMSO; normal' at '6 hour'.log2foldchange\": 1,\n",
       " \"'sulforaphane; normal' at '6 hour' vs 'DMSO; normal' at '6 hour'.p-value\": 1,\n",
       " \"'sulforaphane; normal' at '6 hour' vs 'DMSO; normal' at '6 hour'.log2foldchange\": 1,\n",
       " \"'sulforaphane; prostate carcinoma' at '24 hour' vs 'DMSO; prostate carcinoma' at '24 hour'.p-value\": 1,\n",
       " \"'sulforaphane; prostate carcinoma' at '24 hour' vs 'DMSO; prostate carcinoma' at '24 hour'.log2foldchange\": 1,\n",
       " \"'sulforaphane; prostate carcinoma' at '6 hour' vs 'DMSO; prostate carcinoma' at '6 hour'.p-value\": 1,\n",
       " \"'sulforaphane; prostate carcinoma' at '6 hour' vs 'DMSO; prostate carcinoma' at '6 hour'.log2foldchange\": 1,\n",
       " \"'sulforaphane; prostate carcinoma' at '24 hour' vs 'sulforaphane; normal' at '24 hour'.p-value\": 1,\n",
       " \"'sulforaphane; prostate carcinoma' at '24 hour' vs 'sulforaphane; normal' at '24 hour'.log2foldchange\": 1,\n",
       " \"'sulforaphane; prostate carcinoma' at '6 hour' vs 'sulforaphane; normal' at '6 hour'.p-value\": 1,\n",
       " \"'sulforaphane; prostate carcinoma' at '6 hour' vs 'sulforaphane; normal' at '6 hour'.log2foldchange\": 1,\n",
       " \"'papillary thyroid carcinoma' vs 'normal'.p-value\": 1,\n",
       " \"'papillary thyroid carcinoma' vs 'normal'.log2foldchange\": 1,\n",
       " \"'miR-203 expressing cells' vs 'control'.p-value\": 1,\n",
       " \"'miR-203 expressing cells' vs 'control'.t-statistic\": 1,\n",
       " \"'miR-203 expressing cells' vs 'control'.log2foldchange\": 1,\n",
       " \"'colorectal cancer metastatic in the liver' vs 'normal'.p-value\": 1,\n",
       " \"'colorectal cancer metastatic in the liver' vs 'normal'.log2foldchange\": 1,\n",
       " \"'primary tumor' vs 'normal'.p-value\": 1,\n",
       " \"'primary tumor' vs 'normal'.log2foldchange\": 1,\n",
       " \"'after docetaxel chemotherapy and androgen deprivation therapy' vs 'before docetaxel chemotherapy and androgen deprivation therapy'.p-value\": 1,\n",
       " \"'after docetaxel chemotherapy and androgen deprivation therapy' vs 'before docetaxel chemotherapy and androgen deprivation therapy'.log2foldchange\": 1,\n",
       " \"'GAPLINC knock down' vs 'control'.p-value\": 1,\n",
       " \"'GAPLINC knock down' vs 'control'.t-statistic\": 1,\n",
       " \"'GAPLINC knock down' vs 'control'.log2foldchange\": 1,\n",
       " \"'AHR siRNA' vs 'control'.p-value\": 1,\n",
       " \"'AHR siRNA' vs 'control'.log2foldchange\": 1,\n",
       " \"'aldehyde dehydrogenase positive' vs 'aldehyde dehydrogenase negative'.p-value\": 1,\n",
       " \"'aldehyde dehydrogenase positive' vs 'aldehyde dehydrogenase negative'.t-statistic\": 1,\n",
       " \"'aldehyde dehydrogenase positive' vs 'aldehyde dehydrogenase negative'.log2foldchange\": 1,\n",
       " \"'JQ1 100 nanomolar' vs 'DMSO' in 'wild type'.p-value\": 1,\n",
       " \"'JQ1 100 nanomolar' vs 'DMSO' in 'wild type'.t-statistic\": 1,\n",
       " \"'JQ1 100 nanomolar' vs 'DMSO' in 'wild type'.log2foldchange\": 1,\n",
       " \"'SUZ12 overexpression' vs 'wild type'.p-value\": 1,\n",
       " \"'SUZ12 overexpression' vs 'wild type'.t-statistic\": 1,\n",
       " \"'SUZ12 overexpression' vs 'wild type'.log2foldchange\": 1,\n",
       " \"'Jun-D knockdown' vs 'control'.p-value\": 1,\n",
       " \"'Jun-D knockdown' vs 'control'.log2foldchange\": 1,\n",
       " \"'c-Jun knockdown' vs 'control'.p-value\": 1,\n",
       " \"'c-Jun knockdown' vs 'control'.log2foldchange\": 1,\n",
       " \"'spheroids' vs 'monolayer'.p-value\": 1,\n",
       " \"'spheroids' vs 'monolayer'.t-statistic\": 1,\n",
       " \"'spheroids' vs 'monolayer'.log2foldchange\": 1,\n",
       " \"'spheroids to monolayer' vs 'monolayer'.p-value\": 1,\n",
       " \"'spheroids to monolayer' vs 'monolayer'.t-statistic\": 1,\n",
       " \"'spheroids to monolayer' vs 'monolayer'.log2foldchange\": 1,\n",
       " \"'breast cancer' vs 'normal'.p-value\": 1,\n",
       " \"'breast cancer' vs 'normal'.t-statistic\": 1,\n",
       " \"'breast cancer' vs 'normal'.log2foldchange\": 1,\n",
       " \"'STAT1 siRNA; interferon gamma; 250 micromolar' vs 'STAT1 siRNA; none; '.p-value\": 1,\n",
       " \"'STAT1 siRNA; interferon gamma; 250 micromolar' vs 'STAT1 siRNA; none; '.t-statistic\": 1,\n",
       " \"'STAT1 siRNA; interferon gamma; 250 micromolar' vs 'STAT1 siRNA; none; '.log2foldchange\": 1,\n",
       " \"'STAT1 siRNA; interferon gamma; 250 micromolar' vs 'control; interferon gamma; 250 micromolar'.p-value\": 1,\n",
       " \"'STAT1 siRNA; interferon gamma; 250 micromolar' vs 'control; interferon gamma; 250 micromolar'.t-statistic\": 1,\n",
       " \"'STAT1 siRNA; interferon gamma; 250 micromolar' vs 'control; interferon gamma; 250 micromolar'.log2foldchange\": 1,\n",
       " \"'STAT1 siRNA; interferon gamma; 250 micromolar' vs 'control; none; '.p-value\": 1,\n",
       " \"'STAT1 siRNA; interferon gamma; 250 micromolar' vs 'control; none; '.t-statistic\": 1,\n",
       " \"'STAT1 siRNA; interferon gamma; 250 micromolar' vs 'control; none; '.log2foldchange\": 1,\n",
       " \"'STAT1 siRNA; none; ' vs 'control; none; '.p-value\": 1,\n",
       " \"'STAT1 siRNA; none; ' vs 'control; none; '.t-statistic\": 1,\n",
       " \"'STAT1 siRNA; none; ' vs 'control; none; '.log2foldchange\": 1,\n",
       " \"'control; interferon gamma; 250 micromolar' vs 'control; none; '.p-value\": 1,\n",
       " \"'control; interferon gamma; 250 micromolar' vs 'control; none; '.t-statistic\": 1,\n",
       " \"'control; interferon gamma; 250 micromolar' vs 'control; none; '.log2foldchange\": 1,\n",
       " \"'FOXA1' vs 'control'.p-value\": 1,\n",
       " \"'FOXA1' vs 'control'.t-statistic\": 1,\n",
       " \"'FOXA1' vs 'control'.log2foldchange\": 1,\n",
       " \"'KBM-7; diploid' vs 'KBM-7; haploid'.p-value\": 1,\n",
       " \"'KBM-7; diploid' vs 'KBM-7; haploid'.t-statistic\": 1,\n",
       " \"'KBM-7; diploid' vs 'KBM-7; haploid'.log2foldchange\": 1,\n",
       " \"'c-MYC knockdown' vs 'none' in 'HeLa'.p-value\": 1,\n",
       " \"'c-MYC knockdown' vs 'none' in 'HeLa'.t-statistic\": 1,\n",
       " \"'c-MYC knockdown' vs 'none' in 'HeLa'.log2foldchange\": 1,\n",
       " \"'c-MYC knockdown' vs 'none' in 'MCF-7'.p-value\": 1,\n",
       " \"'c-MYC knockdown' vs 'none' in 'MCF-7'.t-statistic\": 1,\n",
       " \"'c-MYC knockdown' vs 'none' in 'MCF-7'.log2foldchange\": 1,\n",
       " \"'Snail overexpression' vs 'control'.p-value\": 1,\n",
       " \"'Snail overexpression' vs 'control'.t-statistic\": 1,\n",
       " \"'Snail overexpression' vs 'control'.log2foldchange\": 1,\n",
       " \"'siZNF217' vs 'control'.p-value\": 1,\n",
       " \"'siZNF217' vs 'control'.log2foldchange\": 1,\n",
       " \"'expression of wild type RBM47' vs 'empty vector'.p-value\": 1,\n",
       " \"'expression of wild type RBM47' vs 'empty vector'.log2foldchange\": 1,\n",
       " \"'shGATA' vs 'control' in '22Rv1-DR'.p-value\": 1,\n",
       " \"'shGATA' vs 'control' in '22Rv1-DR'.log2foldchange\": 1,\n",
       " \"'shGATA' vs 'control' in 'ARCaPM-DR'.p-value\": 1,\n",
       " \"'shGATA' vs 'control' in 'ARCaPM-DR'.log2foldchange\": 1,\n",
       " \"'shGATA' vs 'control' in 'DU145-DR'.p-value\": 1,\n",
       " \"'shGATA' vs 'control' in 'DU145-DR'.log2foldchange\": 1,\n",
       " \"'ZNA; 30 micromolar' vs 'DMSO' at '12 hour'.p-value\": 1,\n",
       " \"'ZNA; 30 micromolar' vs 'DMSO' at '12 hour'.log2foldchange\": 1,\n",
       " \"'ZNA; 30 micromolar' vs 'DMSO' at '3 hour'.p-value\": 1,\n",
       " \"'ZNA; 30 micromolar' vs 'DMSO' at '3 hour'.log2foldchange\": 1,\n",
       " \"'small cell lung carcinoma' vs 'normal'.p-value\": 1,\n",
       " \"'small cell lung carcinoma' vs 'normal'.log2foldchange\": 1,\n",
       " \"'ING2 targeting' vs 'control'.p-value\": 1,\n",
       " \"'ING2 targeting' vs 'control'.t-statistic\": 1,\n",
       " \"'ING2 targeting' vs 'control'.log2foldchange\": 1,\n",
       " \"'TCF7L2 siRNA' vs 'control'.p-value\": 1,\n",
       " \"'TCF7L2 siRNA' vs 'control'.log2foldchange\": 1,\n",
       " \"'1.25 micromolar dose of sapphyrin PCI-2050' vs '5 percent dose of mannitol'.p-value\": 1,\n",
       " \"'1.25 micromolar dose of sapphyrin PCI-2050' vs '5 percent dose of mannitol'.t-statistic\": 1,\n",
       " \"'1.25 micromolar dose of sapphyrin PCI-2050' vs '5 percent dose of mannitol'.log2foldchange\": 1,\n",
       " \"'2.25 micromolar dose of sapphyrin PCI-2050' vs '5 percent dose of mannitol'.p-value\": 1,\n",
       " \"'2.25 micromolar dose of sapphyrin PCI-2050' vs '5 percent dose of mannitol'.t-statistic\": 1,\n",
       " \"'2.25 micromolar dose of sapphyrin PCI-2050' vs '5 percent dose of mannitol'.log2foldchange\": 1,\n",
       " \"'5 microgram per milliliter dose of actinomycin D' vs '5 percent dose of mannitol'.p-value\": 1,\n",
       " \"'5 microgram per milliliter dose of actinomycin D' vs '5 percent dose of mannitol'.t-statistic\": 1,\n",
       " \"'5 microgram per milliliter dose of actinomycin D' vs '5 percent dose of mannitol'.log2foldchange\": 1,\n",
       " \"'tumour staging pT1; disease staging 2; neoplasm' vs 'normal tissue adjacent to neoplasm'.p-value\": 1,\n",
       " \"'tumour staging pT1; disease staging 2; neoplasm' vs 'normal tissue adjacent to neoplasm'.t-statistic\": 1,\n",
       " \"'tumour staging pT1; disease staging 2; neoplasm' vs 'normal tissue adjacent to neoplasm'.log2foldchange\": 1,\n",
       " \"'tumour staging pT3; disease staging 2; neoplasm' vs 'normal tissue adjacent to neoplasm'.p-value\": 1,\n",
       " \"'tumour staging pT3; disease staging 2; neoplasm' vs 'normal tissue adjacent to neoplasm'.t-statistic\": 1,\n",
       " \"'tumour staging pT3; disease staging 2; neoplasm' vs 'normal tissue adjacent to neoplasm'.log2foldchange\": 1,\n",
       " \"'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit'.p-value\": 1,\n",
       " \"'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit'.t-statistic\": 1,\n",
       " \"'benign hyperplastic enlarged lobular unit' vs 'normal terminal duct lobular unit'.log2foldchange\": 1,\n",
       " \"'mammosphere cell' vs 'breast tumor cell'.p-value\": 1,\n",
       " \"'mammosphere cell' vs 'breast tumor cell'.t-statistic\": 1,\n",
       " \"'mammosphere cell' vs 'breast tumor cell'.log2foldchange\": 1,\n",
       " \"'Msi1 knockdown' vs 'control shRNA'.p-value\": 1,\n",
       " \"'Msi1 knockdown' vs 'control shRNA'.log2foldchange\": 1,\n",
       " \"'Msi1, Msi2 double knockdown' vs 'control shRNA'.p-value\": 1,\n",
       " \"'Msi1, Msi2 double knockdown' vs 'control shRNA'.log2foldchange\": 1,\n",
       " \"'Msi2 knockdown' vs 'control shRNA'.p-value\": 1,\n",
       " \"'Msi2 knockdown' vs 'control shRNA'.log2foldchange\": 1,\n",
       " \"'hypoxia' vs 'normal atmospheric oxygen pressure' in 'high metastatic cell line'.p-value\": 1,\n",
       " \"'hypoxia' vs 'normal atmospheric oxygen pressure' in 'high metastatic cell line'.t-statistic\": 1,\n",
       " \"'hypoxia' vs 'normal atmospheric oxygen pressure' in 'high metastatic cell line'.log2foldchange\": 1,\n",
       " \"'hypoxia' vs 'normal atmospheric oxygen pressure' in 'low metastatic cell line'.p-value\": 1,\n",
       " \"'hypoxia' vs 'normal atmospheric oxygen pressure' in 'low metastatic cell line'.t-statistic\": 1,\n",
       " \"'hypoxia' vs 'normal atmospheric oxygen pressure' in 'low metastatic cell line'.log2foldchange\": 1,\n",
       " \"'primary tumor' vs 'adjacent non-tumor colon' in 'colorectal cancer'.p-value\": 1,\n",
       " \"'primary tumor' vs 'adjacent non-tumor colon' in 'colorectal cancer'.log2foldchange\": 1,\n",
       " \"'EGFR inhibition resistant' vs 'EGFR inhibition sensitive'.p-value\": 1,\n",
       " \"'EGFR inhibition resistant' vs 'EGFR inhibition sensitive'.t-statistic\": 1,\n",
       " \"'EGFR inhibition resistant' vs 'EGFR inhibition sensitive'.log2foldchange\": 1,\n",
       " \"'70 micromolar; docosahexaenoic acid' vs 'ethanol' in 'SW480' at '12 hour'.p-value\": 1,\n",
       " \"'70 micromolar; docosahexaenoic acid' vs 'ethanol' in 'SW480' at '12 hour'.t-statistic\": 1,\n",
       " \"'70 micromolar; docosahexaenoic acid' vs 'ethanol' in 'SW480' at '12 hour'.log2foldchange\": 1,\n",
       " \"'70 micromolar; docosahexaenoic acid' vs 'ethanol' in 'SW620' at '48 hour'.p-value\": 1,\n",
       " \"'70 micromolar; docosahexaenoic acid' vs 'ethanol' in 'SW620' at '48 hour'.t-statistic\": 1,\n",
       " \"'70 micromolar; docosahexaenoic acid' vs 'ethanol' in 'SW620' at '48 hour'.log2foldchange\": 1,\n",
       " \"'70 micromolar; docosahexaenoic acid' vs 'ethanol' in 'SW620' at '12 hour'.p-value\": 1,\n",
       " \"'70 micromolar; docosahexaenoic acid' vs 'ethanol' in 'SW620' at '12 hour'.t-statistic\": 1,\n",
       " \"'70 micromolar; docosahexaenoic acid' vs 'ethanol' in 'SW620' at '12 hour'.log2foldchange\": 1,\n",
       " \"'70 micromolar; docosahexaenoic acid' vs 'ethanol' in 'SW480' at '24 hour'.p-value\": 1,\n",
       " \"'70 micromolar; docosahexaenoic acid' vs 'ethanol' in 'SW480' at '24 hour'.t-statistic\": 1,\n",
       " \"'70 micromolar; docosahexaenoic acid' vs 'ethanol' in 'SW480' at '24 hour'.log2foldchange\": 1,\n",
       " \"'70 micromolar; docosahexaenoic acid' vs 'ethanol' in 'SW480' at '48 hour'.p-value\": 1,\n",
       " \"'70 micromolar; docosahexaenoic acid' vs 'ethanol' in 'SW480' at '48 hour'.t-statistic\": 1,\n",
       " \"'70 micromolar; docosahexaenoic acid' vs 'ethanol' in 'SW480' at '48 hour'.log2foldchange\": 1,\n",
       " \"'70 micromolar; docosahexaenoic acid' vs 'ethanol' in 'SW620' at '24 hour'.p-value\": 1,\n",
       " \"'70 micromolar; docosahexaenoic acid' vs 'ethanol' in 'SW620' at '24 hour'.t-statistic\": 1,\n",
       " \"'70 micromolar; docosahexaenoic acid' vs 'ethanol' in 'SW620' at '24 hour'.log2foldchange\": 1,\n",
       " \"'SN38; 5 nanomolar' at '12 hour' vs 'none; ' at '0 hour'.p-value\": 1,\n",
       " \"'SN38; 5 nanomolar' at '12 hour' vs 'none; ' at '0 hour'.t-statistic\": 1,\n",
       " \"'SN38; 5 nanomolar' at '12 hour' vs 'none; ' at '0 hour'.log2foldchange\": 1,\n",
       " \"'SN38; 5 nanomolar' at '24 hour' vs 'none; ' at '0 hour'.p-value\": 1,\n",
       " \"'SN38; 5 nanomolar' at '24 hour' vs 'none; ' at '0 hour'.t-statistic\": 1,\n",
       " \"'SN38; 5 nanomolar' at '24 hour' vs 'none; ' at '0 hour'.log2foldchange\": 1,\n",
       " \"'SN38; 5 nanomolar' at '6 hour' vs 'none; ' at '0 hour'.p-value\": 1,\n",
       " \"'SN38; 5 nanomolar' at '6 hour' vs 'none; ' at '0 hour'.t-statistic\": 1,\n",
       " \"'SN38; 5 nanomolar' at '6 hour' vs 'none; ' at '0 hour'.log2foldchange\": 1,\n",
       " \"'ASCL1-1 siRNA knockdown' vs 'control'.p-value\": 1,\n",
       " \"'ASCL1-1 siRNA knockdown' vs 'control'.t-statistic\": 1,\n",
       " \"'ASCL1-1 siRNA knockdown' vs 'control'.log2foldchange\": 1,\n",
       " \"'ASCL1-2 siRNA knockdown' vs 'control'.p-value\": 1,\n",
       " \"'ASCL1-2 siRNA knockdown' vs 'control'.t-statistic\": 1,\n",
       " \"'ASCL1-2 siRNA knockdown' vs 'control'.log2foldchange\": 1,\n",
       " \"'ASCL1-3 siRNA knockdown' vs 'control'.p-value\": 1,\n",
       " \"'ASCL1-3 siRNA knockdown' vs 'control'.t-statistic\": 1,\n",
       " \"'ASCL1-3 siRNA knockdown' vs 'control'.log2foldchange\": 1,\n",
       " \"'docosahexaenoic acid; 70 micromolar' at '3 hour' vs 'none; ' at '3 hour'.p-value\": 1,\n",
       " \"'docosahexaenoic acid; 70 micromolar' at '3 hour' vs 'none; ' at '3 hour'.t-statistic\": 1,\n",
       " \"'docosahexaenoic acid; 70 micromolar' at '3 hour' vs 'none; ' at '3 hour'.log2foldchange\": 1,\n",
       " \"'docosahexaenoic acid; 70 micromolar' at '6 hour' vs 'none; ' at '6 hour'.p-value\": 1,\n",
       " \"'docosahexaenoic acid; 70 micromolar' at '6 hour' vs 'none; ' at '6 hour'.t-statistic\": 1,\n",
       " \"'docosahexaenoic acid; 70 micromolar' at '6 hour' vs 'none; ' at '6 hour'.log2foldchange\": 1,\n",
       " \"'CBF-beta knock down' vs 'control'.p-value\": 1,\n",
       " \"'CBF-beta knock down' vs 'control'.t-statistic\": 1,\n",
       " \"'CBF-beta knock down' vs 'control'.log2foldchange\": 1,\n",
       " \"'Runx2 knock down' vs 'control'.p-value\": 1,\n",
       " \"'Runx2 knock down' vs 'control'.t-statistic\": 1,\n",
       " \"'Runx2 knock down' vs 'control'.log2foldchange\": 1,\n",
       " ...}"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "columnNamesCount"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "interpreter": {
   "hash": "31f2aee4e71d21fbe5cf8b01ff0e069b9275f58929596ceb00d14d90e3e16cd6"
  },
  "kernelspec": {
   "display_name": "Python 3.7.3 64-bit",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.3"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}